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 The covalent and non-covalent interactions between DNA and external ligands 
and between DNA and itself are critical for cellular function.  An increased knowledge of 
these interactions can be used for the development of disease-fighting agents, specifically 
anti-cancer drugs with improved sensitivity and specificity for tumor cells.  Electrospray 
ionization mass spectrometry (ESI-MS) is useful in the screening and characterization of 
the interactions involving nucleic acids given the speed and small sample sizes that can 
be analyzed.  In this dissertation, ESI-MS is used to characterize covalent and non-
covalent interactions involving DNA to assist in determining how these interactions can 
lead to better therapeutics. 
 The non-covalent binding of ligands to quadruplex oligonucleotides is discussed 
first.  Pyrrole inosine ligands, which bind to guanine bases, were found to interact with 
both quadruplexes and with guanine rich oligonucleotides without a quadruplex structure.   
 vi 
While those interactions were specific with guanine, novel platinum complexes were 
found to form specific interactions with quadruplex structures themselves as the size of 
the ligands matched the size of a guanine quartet.  This allowed the ligands to end-stack 
with quadruplexes with large thymine-rich loops between guanine-rich regions.    
 The non-covalent and covalent interactions between ligands and other DNA 
structures were also studied.  The non-covalent binding of anthracycline ligands to 
mismatched DNA hairpins was probed.  The analysis of solutions of approximately 
equimolar ligand and oligonucleotide indicated preferential binding to the mismatched 
sequences.  Diazirdinyl benzoquinone crosslinkers, including the clinically studied RH1 
and an analogue of RH1, were reacted with a variety of duplex oligonucleotides.  The 
complexes were observed by LC-MS and dissociated using both CID and IRMPD to 
determine the sites of crosslinking.  It was determined that both ligands could form 
interstrand crosslinks in DNA with 5’-GNC or 5’-GNNC sequences.  The RH1 analogue, 
with a bulky phenyl group, formed fewer crosslinks than RH1. 
 In addition to studying DNA/ligand interactions, the interactions between 
oligonucleotides were also probed.   Oligonucleotides containing non-standard 
isoguanine repeats were annealed in the presence of various cations to determine how 
those cations would affect the resulting secondary structures.  In most cases, isoguanine 
containing strands formed pentaplexes rather than quadruplexes, which were observed for 
strands containing guanine bases.   
 vii 
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Chapter 1: Introduction 
 A major focus of anti-cancer research is on developing new ligands that interact 
with DNA.  As DNA is critical in both replication and in normal cellular function, 
altering DNA through non-covalent or covalent binding can significantly change the cell 
life cycle and can result in cell death.  The design of new anti-cancer ligands often 
involves the creation and comparison of many different variants of a given molecule 
followed by intensive testing to determine the best combination of efficacy in tumor-
tissue and low-toxicity in normal tissue.  Mass spectrometry can be a useful tool in this 
process.  While traditional ionization methods were not able to ionize large biomolecular 
complexes, electrospray ionization (ESI) can transfer large, non-covalent biomolecular 
structures directly from the solution phase to the gas phase.1-7  Mass spectrometry is 
especially useful for determining site specific binding of DNA/ligand interactions8, 9 as 
well as comparing the relative affinity of different ligands towards DNA.10-12   
 This dissertation focuses on the use of ESI-MS to study covalent and non-
covalent DNA complexes.  In this introduction, nucleic acid structures and complexes are 
reviewed as well as the use of ESI-MS to study these complexes.  The chapter closes with 
an overview of the following chapters.   
1.1 DNA STRUCTURES 
  Nucleic acids are the basis of cellular growth and reproduction, and probing the 
interactions involving DNA structures is crucial to understanding cellular processes. 
DNA exists in several forms throughout the lifetime of the cell in response to the cellular 
environment.  In what might be termed a resting state, DNA is coiled in a double helix 
which is folded around itself in a supercoil.  Supercoiled DNA wraps around histones, 
which allows the cell to collapse a massive biomolecule into an efficiently packed 
structure.13  During replication or transcription, the supercoil is unfolded and the helix is 
unzipped to expose the bases at the center of the helix.  
 While the overall structure of cellular DNA is a double stranded helix, there are 
many variations of and changes that occur to this core structure that are important to 
cellular function.  The helix itself can take several forms depending on the environmental 
conditions as well as the DNA sequence.  For example, A and B form DNA are both right 
handed helices, but the A form, which occurs under non-physiological conditions such as 









Figure 1.1 Cartoon approximations of A and B form DNA.  Both are right handed 




 In addition to the common duplex, some segments of DNA can be single 
stranded.  This most notably occurs during transcription or replication when the DNA 
helix opens to allow for the binding of DNA replication enzymes.  Another structure 
found in the cell is the triple-stranded helix.  Triple stranded DNA involves a short 
oligonucleotide binding in the major groove of B form DNA.  The B-form DNA is 
stabilized by canonical base pairs.  The third strand is bound to the helix through 
Hoogsteen or reverse Hoogsteen hydrogen bonding.17, 18  Hoogsteen interactions are 
alternatives to Watson-Crick base pairing and involve interactions between bases through 
different functional groups (Figure 1.2).  Hoogsteen interactions can occur between 
traditional Watson-Crick base pairs such as adenine and thymine as well as nontraditional 
base pairs such as guanine bound to guanine or guanine bound to adenine.  For example, 
a repeat of d(GA)n in a B-form duplex with the complementary d(CT)n strand could have 
another d(CT)n strand bound in the minor groove of the duplex.17, 19  It has been shown 




































Watson-Crick Hoogsteen  
Figure 1.2 Two types of base pairing involving guanine bases.  Hoogsteen binding 
between guanines is the basis for G-quartet formation.   
 3 
 4 
 Other structures adopted by physiological DNA are modulated by sequence.  For 
example, cytosine rich DNA can form i-motif structures under low pH conditions.  In this 
structure, protonated and neutral cytosine bases interact to form a non-canonical base pair 
and a non-helical folded structure.20-22  However, the most well known non-duplex 
structure is the guanine quadruplex.  Quadruplexes are formed from guanine rich DNA 
strands that often consist of guanine repeats separated by thymine and adenine rich 
regions.  The basis of a G-quadruplex is formed by the interaction of four guanine bases.  
Rather than forming conventional Watson-Crick base pairs with cytosine, the four 
guanines interact with one another through Hoogsteen interactions, and form a planar 
quartet.23-26  In most cases, the guanine bases surround a central cation that, 
physiologically, is often potassium or sodium (Figure 1.3a).27-29  There is a large array of 
possible quadruplex structures based on the sequences of the strands involved as well as 
the environmental conditions.  Specifically, quadruplexes can be inter- or intramolecular 
and multiple conformations of intramolecular quadruplexes are possible (Figure 1.3b).23, 
25, 26, 30-35  G-quadruplexes have been intensively studied due to their role in replication.  
Telomeres, non-coding guanine rich regions at the ends of DNA, allow the cell to 
replicate multiple times and shorten each time the cell replicates.  In immortal cancer 
cells, telomeres maintain their length despite repeated replication cycles which permits 
many more replications to occur before cell death is initiated.36  Telomerase, the protein 
that lengthens telomeres and thereby extends the life of a cell, can only bind to the single 
 
Figure 1.3 a.  Structure of a guanine tetrad around a central metal cation.  b.  Schematic 
of intermolecular and intramolecular quadruplexes.  Arrow heads point to 
the 3’ end of the nucleic acid strands.   
strand conformation of the telomere.37  If the quadruplex conformation of the telomere is  
stabilized, telomerase cannot bind and the lifespan of the cell can be limited- an 
important factor in controlling cancer.36, 38-40 
 While biological DNA structures have obvious import, non-biological structures 
are also of interest.  The ability to self-assemble and the variety of structures that nucleic 
acids and DNA can take make DNA an option for sensing and ion transport 
applications.41-47   DNA microarrays in which immobilized arrays of single strands are 
hybridized with fluorescently labeled target DNA in solution.  After washing, the 
fluorescent areas of the array can be excised and sequenced.  This technique is used in 
genomics for gene expression and discovery.46  The structure of DNA itself can also be 
used in ion transport applications.  For example, the ability of guanine rich nucleic acids 
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to self-assemble into guanine quartets has been applied to the formation of passive 
transport channels.44, 47  Once modified nucleotides are allowed to form into quartet 
structures, the central cavity permits small cations to traverse the channel while larger 
compounds cannot.  Using bases other than guanine can change the dynamics between 
the bases and create ion channels of other sizes.42, 45, 48 
1.2 DNA STRUCTURE BY ESI-MS 
 While mass spectrometry cannot directly image the structures formed by DNA 
strands, a great deal of information can be gained through interrogation by mass 
spectrometry.  The most basic information is obviously the size of the complex and the 
number of strands involved which is readily determined based on the mass-to-charge 
ratio of the ions observed in the mass spectra.  However, mass spectrometry has also been 
used to determine the relative stabilities of gas-phase quadruplexes.49  Also, ESI-MS has 
been used to characterize the number of cations bound in the central cavities of 
quadruplexes.50 
 Also of great use in the study of DNA structures has been ion mobility mass 
spectrometry.51-55  This technique involves the ionization of the molecules under study 
followed by allowing the ions to travel through a gas-filled chamber before mass-
selective detection.  In addition to gaining information on the mass to charge ratios of the 
analytes, the analytes separate by the size, shape and charge of the ions while traveling in 
the drift tube.  With this technique, it was determined that gas phase A-T base pair rich 
duplex DNA is closer to B-DNA while gas phase G-C rich DNA is more like A-form 
 7 
DNA.54, 55  In addition, the smallest duplex that can retain a duplex conformation into the 
gas phase, a minimum of eight base pairs are required, was determined as well.54, 55  
Quadruplex structures based on the human telomeric sequence were studied by ion 
mobility mass spectrometry and were shown to remain in a quadruplex structure in the 
gas phase.52, 56  
1.3 DNA/LIGAND COMPLEXES 
 DNA interactive agents have been studied for their use as anti-cancer and anti-
bacterial drugs.40, 57-60  While DNA binding varies from non-specific interactions to 
interactions based on sequence and local structure, most therapeutic DNA binding is 
specific.  Since alteration of DNA though ligand binding changes the function of the cell, 
the ideal drugs would selectively bind only to DNA in diseased cells to limit any effects 
in normal tissues.  This need for selectivity is especially great in cancer cells since they 
are essentially normal cells that have begun replicating aggressively. 
 Non-covalent DNA binding ligands can bind in several ways (Figure 1.4).  
Electrostatic binding ligands bind non-specifically to the outside of DNA duplexes.  The 
negative charge of the sugar-phosphate backbone can allow for positively charged 
ligands to associate with the duplex without base interactions.  Molecules that exhibit this 
kind of binding include metal cations, such as sodium or magnesium, as well as small 
cationic ligands such as 1,3-propane diammonium.  In most cases, multiply charged 
cations bind more strongly than singly charged cations.61  Minor groove binders do form 
specific interactions with the narrow shape of the minor groove at A/T rich sites.  These 
Minor Groove IntercalationElectrostatic 
 
Figure 1.4 Illustrations of common non-covalent DNA interactions. 
types of ligands, such as distamycin and netropsin, form hydrogen bonds with bases in 
the minor groove.62-65  The groove at G/C rich regions is wider and the interactions with 
ligands aren’t as strong.  Another type of binding is intercalation.  DNA intercalators are 
generally planar ligands that are capable of fitting between stacked bases within the 
duplex.58, 60, 66  Two molecules that bind intercalatively are ethidium bromide and 
daunomycin.  The intercalating ligands are bound by π stacking interactions between the 
ligand and bases.  With duplexes, intercalation causes distortion of the helix and duplex 
lengthening as the bases must adjust to fit the ligand between stacked bases.16, 61  
Intercalation is most commonly found in G/C rich regions and can also be seen with G-
quadruplexes.  However, ligands that interact with quadruplexes most often do so by base 
stacking to the top or bottom of the quadruplex rather than intercalation as the energetic 
cost of insertion into and disruption of the quadruplex is too great.67, 68  
 There are many ligands that form covalent attachments to DNA, primarily at 
reactive sites on the nucleobases.  Binding can occur at all four nucleobases and at 
different sites on those nucleobases, but several sites are more nucleophilic and more 
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reactive.  The most nucleophilic site on any of the bases is the N7 position on guanine.  
This is a frequent site of covalent adduction by small molecules such as dimethyl sulfate 
(Figure 1.5a) as well as larger molecules such as nitrogen mustards.69  Another reactive 
site is the N3 of adenine which sits in the minor groove.  The antibiotic duocarmycin and 
its analogues bind at this site (Figure 1.5b).70, 71  Anti-cancer and antibiotic agents are 
often based on a covalent binding functionality since covalently bound adducts can lead 
to errors in the replication process that induce apoptosis in cancer cells.  Covalent binding 
can refer to simple methylation of a base72 or to covalent crosslinking between the two 
DNA strands73, 74 or between a DNA strand and protein.75-77  DNA interstrand crosslinks 
are particularly damaging to the cell as they prevent unzipping of the duplex which 
results in a failure to transcribe or replicate.  Crosslinking agents have been used 


































Figure 1.5 Examples of covalent modifications to guanine (a) and adenine (b). 
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1.4 ESI-MS OF DNA/LIGAND COMPLEXES 
 ESI-MS is a versatile method for analyzing DNA/ligand complexes.  Many 
aspects of binding can be assessed from a mass spectrum, and the technique is fast 
compared to gel electrophoresis allowing for high-throughput analysis.  The relative 
binding affinities of various ligands can be compared based on a comparison of the ion 
abundances for different DNA/ligand complexes,10, 12, 78-80 and the stoichiometries of the 
DNA/ligand complexes are readily apparent based on the m/z values of the complexes.  
The results are acquired in a non-native gas-phase environment, but ESI affords a fast, 
gentle means of transferring the complexes into the gas-phase with minimal disruption of 
non-covalent interactions. 
 While the determination of selectivity and stoichiometries of non-covalent 
complexes is readily performed, determining the site of reactivity can be more difficult.  
Reactions at different sites have the same mass so tandem mass spectrometry must be 
used to generate fragmentation patterns to probe the structures of the complexes.  
However, the most common dissociation event for non-covalent DNA/ligand complexes 
is often ejection of the ligand, which does not indicate the site of binding.  To provide 
information about the location of non-covalent binding, chemical probes techniques can 
be used.  Chemical probes are small molecules that covalently attach to a target site and 
are used to study structures and interactions in nucleic acid and protein complexes.   
Chemical probes and footprinting reactions have often been used to probe ligand binding 
sites and DNA conformations in solution.81-85  In footprinting reactions, probe molecules 
are added to solutions containing the DNA/ligand complexes and the probes are allowed 
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to covalently bind.  The DNA is then digested and sequenced to determine where the 
probe was able or unable to react.  These unreacted sites indicate where the ligand was 
bound along the DNA.82, 84, 85  While informative, these reactions are usually analyzed by 
gel electrophoresis which can have lower resolution and take longer than mass 
spectrometric analysis.  For a mass spectrometric alternative, covalent binding between 
the chemical probe and the DNA/ligand complex is performed in solution as usual.  
Following clean up, the solution is analyzed by mass spectrometry to detect complexes 
containing the chemical probe.  The DNA/chemical probe complex is then dissociated to 
pinpoint the site of reaction based on the fragmentation pattern and the observed mass 
shifts in some of the product ions.  In the case of duplex/ligand binding, the ligand is 
allowed to incubate with the DNA for a period of time before addition of the chemical 
probe.  As before, the sample is cleaned up and analyzed to detect the DNA/ligand/probe 
complexes and dissociation is performed on those complexes.  For these complexes, the 
presence of greater reaction in a given region can signify local unwinding of the helix 
which indicates the non-covalent binding site.86 
 Covalent DNA/ligand interactions have also been studied with mass spectrometry.  
One technique used to characterize covalent modifications is the digestion of DNA to 
create individual bases.  LC-MS/MS of the resulting bases can provide information on the 
types of bases that are covalently modified, based on the change in mass, as well as 
detailed structural information about the modification but cannot provide information as 
to where the modification occurred within the sequence.87-91  Crosslinked DNA can also 
be analyzed in the same fashion.87, 92-94  Alternatively, intact duplex/ligand adducts can be 
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directly subjected to tandem mass spectrometry, and the resulting fragmentation patterns 
can be interpreted.   
1.5 DISSOCIATION TECHNIQUES FOR DNA 
 An advantage of mass spectrometry is the ability to gain structural information for 
a given analyte by dissociating the ion into fragments.  The most common method of 
dissociation in mass spectrometry is collisionally induced dissociation (CID).  To 
perform CID in an ion trap, the precursor ion is isolated within the trap.  Application of 
an AC voltage causes translational excitation of the ion, leading to energetic collisions 
with the helium buffer gas. The collisions cause conversion of kinetic energy to internal 
energy promoting dissociation in a distinct fragmentation pattern for that ion.   CID is a 
low energy fragmentation technique which, for single stranded DNA, often results in loss 
of a base-a relatively uninformative fragmentation pathway.  Upon CID, duplexes can 
dissociate through two pathways: by base loss similar to single strand DNA or by strand 
separation to the individual strands.   
 Infrared multiphoton photodissociation (IRMPD) is another means to dissociate 
ions.  With IRMPD, photons, usually from a CO2 laser at a wavelength of 10.6 μm, are 
used to activate the precursor ion.  This requires that the precursor ion be capable of 
absorbing photons at the wavelength of the laser.  Phosphate groups and sulfate groups 
both absorb at 10.6 μm making DNA, with its sugar-phosphate backbone, highly 
chromogenic at this wavelength.  Both single stranded and double stranded 
oligonucleotides have been dissociated by IRMPD,95 and complexes between duplexes 
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and small molecules have also been studied.96, 97  There are advantages to IRMPD in 
comparison to CID that apply to all molecules and that apply to DNA in particular.  CID 
requires collisions with helium molecules and excitation of ion trajectories which can 
scatter the ions and lower signal.  In addition, in order to maximize the efficiency and 
energetics of the collisions, the trapping voltages are raised to a level that prevents 
trapping of lower m/z ions.  This can result in the loss of informative low mass 
fragments.  In comparison, in IRMPD the lack of energetic collisions and the absence of 
excitation of the kinetic energies of the ions prevent loss of ions due to scattering.  Also, 
the trapping voltages are not raised during IRMPD thus retaining low mass ions.  Since 
the fragment ions are also irradiated during activation, IRMPD can result in multi-step 
fragmentation, termed secondary fragmentation, which gives more information about the 
structure of the precursor ion.  Since the activation waveform for CID is only applied to 
the precursor ion, multistage fragmentation requires step-by-step isolation and 
dissociation of individual fragment ions which is often limited by signal intensity.  For 
DNA specifically, the secondary fragmentation mechanism of IRMPD gives much more 
sequence information than CID, the latter which is dominated by base loss.  As with CID, 
the primary fragmentation pathway in IRMPD is often base loss.  However, these base 
loss ions readily absorb IR photons and are converted to informative sequence ions, 
making IRMPD a powerful tool for DNA analysis.   
 Recently, other dissociation methods have been successfully used for the 
characterization of DNA.  While not further discussed in this dissertation, it is useful to 
briefly highlight some of their advantages.  Electron based dissociation methods have 
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become popular in mass spectrometry in recent years.98-101  Electron capture dissociation 
(ECD),102, 103 which uses an electron beam to energize and dissociate ions via an 
exothermic electron transfer process, and electron transfer dissociation (ETD),104-107 in 
which reagent anions are allowed to react with analyte cations to cause an exothermic 
electron transfer process, have become popular dissociation methods especially in 
proteomics applications.  However, since these methods involve cationic analytes, they 
are not often used with DNA.  Recently, DNA cations have been interrogated by ECD103, 
108, 109 and ETD.110  Combining the electron-based activation process with collision 
induced dissociation provided a wide range of backbone fragments not usually observed 
with CID alone.  In the negative mode, electron detachment dissociation (EDD) using a 
UV laser also provides novel backbone fragments due to the creation of radical 
intermediates.111, 112 
1.6 OVERVIEW OF CHAPTERS 
This dissertation is intended to further exploration of the uses of ESI-MS for the 
analysis of oligonucleotide complexes.  Chapter 2 is a brief description of some of the 
techniques used in the experiments performed for this work.  Both Chapters 3 and 4 
discuss the non-covalent binding of novel ligands to quadruplex DNA.     In Chapter 3, a 
pyrrole inosine ligand, which can form Hoogsteen interactions with guanine, was found 
to bind selectively to G-quadruplexes and to guanine rich oligonucleotides.  Two control 
ligands either with no Hoogsteen binding functionality or with a steric block to binding 
showed similar levels of binding to all oligonucleotides.   
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Chapter 4 focuses on transition metal complexes as non-covalent G-quadruplex 
binding ligands.  Due to the extensive π bonding surface area of the Pt ligands, the 
ligands showed increased binding to guanine quadruplexes over smaller Ru based 
complexes.  The length of the thymine loops between guanine repeats had a significant 
effect on ligand binding.  Little binding was observed with single strand or duplex 
oligonucleotides. 
In Chapter 5, the use of two non-covalent ligands to bind preferentially to thymine 
mismatches was studied.  The ligands, doxorubicin and daunorubicin, were studied with 
hairpin oligonucleotides that either consisted of a wild-type sequence or sequences with 
one or two cytosine to thymine mutations.  The ligands exhibited greater affinity for the 
mismatched hairpins over the wild-type hairpins at equimolar concentrations.   
Chapter 6 focuses on the covalent crosslinking of duplex DNA through 
benzoquinone-based crosslinkers.  The two crosslinkers under study can for interstrand 
crosslinks at the N7 site on guanine bases.  Crosslinking was determined to be sequence 
dependent with a minimum of one base pair required between opposite strand guanines 
required for crosslinks to form.  A large phenyl group on one of the crosslinkers 
minimized the ability of that ligand to form crosslinks.  Both the local and global 
secondary structures of the duplexes were determined to be important for crosslink 
formation.   
While the other chapters concern ligand binding, Chapter 7 focuses on the 
structures of oligonucleotides themselves.  Specifically, strands containing a non-
standard base, isoguanine, were studied to determine the effects of annealing the strands 
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in the presence of different cations.  While it is known that isoguanine bases prefer 
pentad structures over the tetrad structures favored by guanine bases, it was unclear how 
changing the annealing cation would affect the final oligonucleotide structures.  In most 
cases, singly and doubly charged cations resulted in the formation of pentaplex structures.  
However, potassium and, under certain conditions, ammonium, could facilitate the 
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Chapter 2: Experimental Methods 
All mass spectrometry described in the following chapters was performed with 
electrospray ionization (ESI) which allows for gentle ionization of large, non-covalent 
biomolecular complexes.  This chapter describes DNA annealing conditions and briefly 
outlines the instrumental conditions for the mass spectrometric and solution phase 
experiments.  Fragmentation nomenclature for nucleic acids is also described.   
2.1 DNA ANNEALING CONDITIONS  
 In order to form the non-covalent interactions between oligonucleotides, samples 
were annealed in the presence of salts.  The cations present in the salts facilitate strand 
interaction by limiting the repulsive effects of the negatively charged phosphate 
backbone.  In most cases, the salt used was ammonium acetate.  While sodium or 
potassium buffers are usually used in order to best replicate cellular conditions, 
ammonium acetate is a volatile salt.  The ammonium readily separates from the DNA 
backbone during ESI and leaves the DNA ions mostly adduct-free for mass analysis 
while sodium or potassium would remain bound to the DNA and lead to a complex 
distribution of DNA ions containing one or more metal ions.  Standard oligonucleotide 
strands were synthesized on a 1 μmole scale and desalted by IDT DNA, Inc. (Coralville, 
IA).  The strands were resuspended in water and the concentrations confirmed by UV/Vis 
spectroscopy at 260 nm.  To form duplexes, complementary oligonucleotide strands at 
500 μM were combined to form duplexes in the presence of 150 mM ammonium acetate.  
The samples were heated to 90-95oC briefly and allowed to cool to room temperature in a 
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water bath overnight.  The annealing procedure for quadruplexes and other higher order 
structures was similar although both the strand concentrations and salts were often 
adjusted.   
2.2 MASS SPECTROMETRY 
 All mass spectrometric experiments described in this dissertation were undertaken 
on ion trap mass spectrometers.  Traditional 3-D ion traps have the advantages of 
ruggedness, low cost, and the ability to undertake multiple stages of MS in the same 
trapping region.  After the ionization source and ion focusing optics that are common to 
all mass spectrometers, ions enter the ion trapping region through an entrance lens.  The 
trap itself consists of a hyperbolic ring electrode to which an RF voltage is applied.  On 
either side of the ring electrode are entrance and exit endcaps which are typically 
grounded.  If the RF frequency is ramped, the ions become excited in a mass-to-charge 
dependent fashion.  The excited ions fall out of the central ion cloud and eventually are 
ejected from the trap to be detected.  A recent incarnation of the ion trap is the 2-D or 
linear ion trap.  In this case, the trap consists of a quadrupole mass analyzer.  RF voltages 
are applied to opposite rods to create a field that keeps the ion motion along the axis of 
the quadrupoles.  To trap the ions, voltage offsets at either end of the quadrupoles are 
applied.  These voltages can be raised, to trap the ions, or lowered, to permit ions to enter 
or exit the trap.  The ions are ejected radially through slits in the quadrupoles and two 
detectors are used to improve sensitivity.  In addition, the trap geometry itself improves 
sensitivity over the 3-D trap as more ions can occupy the space without interacting with 
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one another.  Additional improvements to scanning speed have also been noted, and 
variations in how voltages are applied to the ion trap have allowed for exciting changes in 
trapping capabilities.  For example, two ion populations with different polarities can be 
trapped simultaneously in the same trap. 
 In this dissertation, experiments were undertaken on Thermo Scientific (San Jose, 
CA) LCQ Duo or LTQ XL mass spectrometers.  Most work was done in negative 
ionization mode with low heated capillary temperatures, around 90oC, to allow for 
desolvation of the ions while retaining non-covalent complexes.  Analyte concentrations 
were around 10 mM in 50 mM ammonium acetate.  The ammonium cations replace 
sodium adducts that electrostatically bind to the backbone of DNA and then are 
evaporated off during the desolvation/ionization process.   
2.3 LC-MS 
 The addition of liquid chromatography is a logical extension of ESI-MS.  While 
ESI excels at the analysis of large biomolecules, excessive salts and complex matrices are 
problematic.  With LC providing sample clean-up as well as separation of the mixture 
components, the eluent can be directly analyzed by ESI-MS.  For good separation of 
oligonucleotides, an ion pairing reagent is often added to the mobile phase in LC 
separations.  To stay compatible with ESI-MS, 10mM ammonium acetate was used as the 
aqueous component to the mobile phase.  The organic component was 50% 
acetonitrile/50% 10 mM ammonium acetate.  The use of aqueous ammonium acetate in 
the organic phase was due to the relatively high, relatively similar polarities of the 
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oligonucleotides and complexes.  It permitted a slow, controlled gradient for elution.  A 
Dionex (Sunnyvale, CA) Ultimate 3000 capillary HPLC system with an Agilent (Santa 
Clara, CA) Zorbax 300SB C18 column (150mm x 0.3 mm, 5 μm particle size) was used 
for all experiments.  The UV trace was collected at 260 nm.   
2.4 NUCLEIC ACIDS DISSOCIATION 
 In the mass spectrometric analysis of nucleic acids, fragmentation is often used to 
further characterize the nature of the interactions.  Terminology has been developed to 
label the fragments resulting from dissociation.  In low energy fragmentation regimes, 
such as collisionally induced dissociation (CID) and infrared multiphoton 
photodissociation (IRMPD), the most common initial fragmentation from a single 
stranded oligonucleotide is often base loss in which the bond between the base and the 
sugar is cleaved.  After base loss, the fragment can be dissociated further at the site of the 
base loss resulting in cleavage of the phosphate backbone.  This fragmentation normally 
occurs 3’ to the sugar at the carbon-oxygen bond resulting in fragments containing the 5’ 
end with a loss of the base, a-base ions, and fragments containing the 3’ end, w ions 
(Figure 2.1).  The fragment ions are further categorized by the number nucleotides 
contained within the fragment which is described by a subscript.  In higher energy 
fragmentation spectra, other ions are present including c and y ions, which are formed 
after dissociation 3’ to the phosphate, and a ions that retain the nucleobase.   
 
Figure 2.1 Fragmentation nomenclature for DNA dissociation.  
2.5 IRMPD 
 IRMPD uses low energy photons from CO2 lasers to energize ions and cause 
dissociation via low energy pathways.   IRMPD has been shown to be an excellent tool 
for the dissociation of oligonucleotides.  In addition to sulfate groups, phosphate groups 
absorb the energy of a CO2 laser well.  As nucleic acids contain a sugar-phosphate 
backbone, there are multiple chromophores for possible absorption of a photon.  IRMPD 
was performed using a 50 W Synrad (Mukilteo, WA) CO2 laser.  The emitted wavelength 
was 10.6 μm.  For the DNA experiments, the laser was operated at 20% power or 10 W, 
nominally.  The irradiation time was 1-10 ms, and the laser was triggered during the 
activation step of the mass spectrometer.  
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2.6 CIRCULAR DICHROISM 
 Circular dichroism is a form of spectroscopy in which circularly polarized light is 
used to interrogate a sample.  The difference in absorption of left and right circularly 
polarized light provides information on the relative orderedness of a given sample.  
Molecules that are chiral or have some inherent ordered structure, such as the stacking of 
base pairs in a duplex oligonucleotide, will result in a difference in absorption at certain 
wavelengths.  When taken together, the resulting spectrum can give information about the 
overall structure of a molecule or complex.  While minor details about the structure are 
often not represented, the technique provides a valuable way to gauge the formation of 
complex.  Circular dichroism experiments were performed on a Jasco, Inc. (Easton, MD) 
J-815 spectropolarimeter.  Spectra were collected over a wavelength range of 220 to 320 
nm, and 3 to 5 spectra were averaged to create the final spectra.  The quartz cuvette used 
had a 1 mm pathlength and solutions were generally 10 μM in concentration.  Blank 
spectra of the buffers were subtracted.   
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Chapter 3: Characterization of the Binding of Pyrrole Inosine Ligands 
to Quadruplex Oligonucleotides 
3.1 OVERVIEW 
Based on binding studies undertaken by electrospray ionization-mass 
spectrometry, a synthetic pyrrole-inosine nucleoside, 1, capable of forming an extended 
three-point Hoogsteen-type hydrogen-bonding interaction with guanine, is shown to form 
specific complexes with two different quadruplex DNA structures  [dTG4T]4 and d(T2G4)4 
as well as guanine rich duplex DNA.  The binding interactions of two other analogs were 
evaluated in order to unravel the structural features that contribute to specific DNA 
recognition. The importance of the Hoogsteen interactions was confirmed through the 
absence of specific binding when the pyrrole NH hydrogen-bonding site was blocked or 
removed.  While 2, with a large blocking group, was not found to interact with virtually 
any form of DNA, 3, with the pyrrole functionality missing, was found to interact non-
specifically with several types of DNA.  The specific binding of 1 to guanine rich DNA 
emphasizes the necessity of careful ligand design for specific sequence recognition.   
3.2  INTRODUCTION 
 A variety of DNA interactive ligands have been developed with a wide range of 
binding modes and targeted applications1-4 such as ones designed to stall replication or 
transcription2, 5, 6 or to stimulate apoptosis7.  Common binding modes of these ligands to 
duplex DNA include minor groove binding and intercalation2-4, 8.  The former is common 
in the deep well of adenine/thymine rich regions, whereas the latter most often occurs in 
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guanine/cytosine rich regions and involves insertion between base pairs in duplex DNA.  
Other ligands have been developed to bind to quadruplex DNA to limit binding and 
activity of telomerase9-18.   There continues to be considerable effort to design and 
construct new DNA interactive agents, ones with greater selectivity for certain DNA 
structures or ones with higher affinities.  The development of these DNA interactive 
ligands is facilitated by rapid, sensitive analytical screening methods that provide 
diagnostic feedback about key issues like binding selectivity and specificity of DNA 
recognition.  Electrospray ionization mass spectrometry (ESI-MS) is one of the newer 
tools used to evaluate DNA interactive ligands and offers the advantages of high 
sensitivity, low sample consumption, and high throughput screening19-21.   Mass 
spectrometric studies of DNA interactive ligands have been effective in characterizing 
binding selectivity and specificity9-11, 16, 22, establishing the mode of binding10, 11, 16, 22, and 
correlating specific binding patterns with in vitro antitumor and antibacterial 
cytotoxicity22.    
 Recently, work presented by our group10, 23 and others11, 16-18, 24-27 has established 
the utility of using ESI-MS to evaluate the binding properties of potential quadruplex-
interactive ligands.  Although many of these prior studies have focused on DNA 
interactive ligands that have been developed as drugs, ESI-MS can also play a role in 
evaluating new DNA binding modalities in the early stages of ligand design, whether for 
new drug platforms, DNA sensors, or targeted DNA cleavage agents.  Because ESI-MS 
offers fast analysis with minimal sample usage, it can be used conveniently to provide 
step-by-step feedback at each state of ligand design, thus allowing systematic 





Scheme 3.1  Structures of synthetic nucleosides, 1-3. 
In this study, we use ESI-MS to examine a pyrrole-inosine based synthetic 
nucleoside, 1 (Scheme 3.1) that is an offspring from a previous water insoluble analog 
that demonstrated the ability to bind DNA via an extended Hoogsteen-type interaction28. 
1 was designed with appropriate functional elements to engage in a series of hydrogen-
bonding interactions with a complementary nucleobase, in this case guanine (Scheme 
3.2).  The present work was undertaken to determine whether 1 binds quadruplexes 
specifically due to their guanine-rich composition and Hoogsteen-stabilized 
conformations or has a more general affinity for guanine bases.  The interactions of 1 
with two different quadruplex-forming oligonucleotides, dTG4T, which forms a four-  
 
 
Scheme 3.2  Hoogsteen binding in guanine tetrads and between 1 and guanine bases. 
stranded intermolecular quadruplex [dTG4T]4, and d(T2G4)4, which forms an 
intramolecular quadruplex, as well as several single-stranded and double-stranded 
oligonucleotide sequences were investigated to probe the selectivity of 1 towards 
different DNA secondary structures.    Single strands and duplexes were chosen with both 
high and low GC content to determine guanine selectivity.  Furthermore, comparative 
experiments were carried out to evaluate the binding of structural analogs of 1 in which 





The general preparation strategy for the synthetic nucleosides 1, 2, and 3, albeit 
bound to different sugars, was described previously by Sessler et al.28.   Oligonucleotides 
were prepared and purified by reversed-phase HPLC by Integrated DNA Technologies 
(Coralville, IA).  Ammonium acetate (98% purity) and A.C.S. Grade Spectranalyzed 
methanol was obtained from ThermoFisher Scientific (Waltham, MA).  All purchased 
chemicals were used without further purification.  Water was purified in house with an 
EASYpure UV deionizer (Barnstead International, Dubuque, IA). 
3.3.2 Preparation of Samples for Analysis.   
 Annealing of d(T2G4)4 (Q1), [dTG4T]4 (Q2), 
dGGCGTCGGCGTCGC/dGCGACGCCGACGCC (DS1), and 
dATAAAAACGAAAATA/ dTATTTTCGTTTTTAT (DS2) was performed by heating a 
1 mM solution of the oligonucleotide in 150 mM ammonium acetate to 90°C followed by 
cooling to room temperature over 2 hours9, 17, 28.  Two single strand oligonucleotide 
sequences were also analyzed: dGGCGTCGGCGTCGC (SS1) and 
dATAAAAACGAAAATA (SS2).  The annealed or single strand oligonucleotides were 
analyzed in a final ammonium acetate concentration of 50 mM and a solvent composition 
of 20% methanol.  A ligand (20-50 μM) was incubated with DNA (10 μM) for 10 
minutes prior to ESI-MS analysis.  
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3.3.3 Methods and Instrumentation.   
Mass spectrometric analyses were performed on a ThermoFinnigan LCQ Duo 
quadrupole ion trap mass spectrometer equipped with the stock ESI source (San Jose, 
CA).  Oligonucleotide samples were analyzed in the negative ion mode with the heated 
capillary set at 80°C.  Source conditions were tuned to minimize in-source fragmentation 
of complexes with a needle voltage of 3.5 kV and a nitrogen sheath gas of 40 arbitrary 
units.  Solutions were infused directly at 3 μL min-1, and the spectra presented represent 
the average of 100 to 200 scans.   Relative binding affinities for each ligand to each type 
of DNA are given as the fraction of bound DNA, expressed as a percentage, which relates 
the total peak areas of the various ligand:DNA complexes to all DNA species (both 
bound and free).  The equation, which has been used in previous studies23, 29, to calculate 
the fraction bound DNA is: 





 where PAn:m represents the peak areas of the various ligand:DNA complexes and PADNA 
denotes the total peak area of free DNA ions.  Peak areas were determined in Origin 7.0 
(OriginLab, Northampton, MA).  A high fraction bound value indicates a higher 
ligand:DNA binding efficiency. Measurement of the peak areas, rather than relative 
abundances, of the complexes permits the inclusion of salt adducts that may not be 
evident upon visual inspection of the mass spectra. 
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3.4 RESULTS AND DISCUSSION 
3.4.1 Interactions with Quadruplex DNA.   
Previous experiments have demonstrated the utility of ESI-MS for analyzing 
quadruplex DNA structures formed from short oligonucleotides10, 11, 16-18, 23, 30, 31. For the 
present study, two of these oligonucleotides were selected to evaluate the interactions 
between quadruplex DNA and the three nucleosides.  The first oligonucleotide, d(T2G4)4, 
forms an intramolecular quadruplex in which one strand is folded into a quadruplex with 
four G-tetrads (Q1). The second oligonucleotide, dTG4T, forms a parallel intermolecular 
quadruplex involving four strands of DNA (Q2), [dTG4T]4. 
Examples of the ESI-mass spectra obtained for the quadruplex and quadruplex/ligand 
solutions are shown in Figure 3.1.  Quadruplex ions in the -4, -5, and -6 charge states are 
observed for Q2 (Figure 3.1a), and the quadruplex/ligand complexes are easily discerned 
and assigned in Figures 3.1b-d based on the characteristic mass shifts caused by the 
bound ligand(s).  Ligand 1 exhibits the greatest relative extent of binding, whereas ligand 
2 engages in very little quadruplex binding.  The bulky tert-butoxycarbonate (BOC) 
group of ligand 2 appears to significantly suppress DNA binding.  Ligand 3 exhibits 
lower binding affinity than 1, and this difference is ascribed to the lack of a third possible 
hydrogen bonding interaction which is possible for 1.  For the three nucleosides, the 
relative quadruplex binding affinity follows the trend 1 > 3 > 2 indicating that the 
improved hydrogen bonding motif and lack of steric interference allows 1 to bind to Q2 
more effectively than the other two compounds. A similar trend was observed for binding 
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to Q1 albeit with greater binding between Q1 and 3 than was seen with Q2 (mass spectral 
results not shown), and the complete set of comparative results is shown in bar graph 
form in Figure 3.2 for easy visual comparison.  The differences in ligand binding between 
Q1 and Q2 are most likely due to the different conformations at either end of each 
quadruplex since the quadruplexes themselves are of the same length.  Since Q1 is an 
intermolecular quadruplex while Q2 is an intramolecular one, the thymidine nucleotides 
at either end of the quadruplexes will be in different conformations: unstructured for Q1 
and in thymidine loops for Q2.  This could create different binding pockets for ligand 
interaction. 
3.4.2 Concentration Dependence of Ligand Binding.   
To evaluate whether the interaction between 1 and quadruplex DNA is a specific 
association or a non-specific aggregation, solutions containing Q2 with varying 
concentrations of 1 were analyzed (Figure 3.3).   The concentration of DNA was fixed at 
10 μM, and the ligand concentration was varied from 20 to 50 to 100 μM.  Over this 
range, the extent of complexation between 1 and Q2 remained unchanged.  The lack of 
dependence of the extent of complexation on the concentration of 1 offers evidence 
against non-specific aggregation between 1 and the quadruplex DNA.  Analogous 
concentration-dependent experiments were carried out with 3 and indicated a significant 
degree of non-specific binding, based on the substantial increase in the stoichiometries of 
the DNA/ligand complexes as well as the notable increase in the fraction of bound DNA 
as the relative concentration of ligand 3 increased (Figure 3.3). For example, up to five 
molecules of 3 are bound to one quadruplex in Figure 3.3f.  The high number of bound 














































































































Figure 3.1  ESI-mass spectra of Q2 (10 μM) alone (a) and with 1 (b), 2 (c), or 3 (d) with 
each ligand at 20 μM.  The label Q indicates the quadruplex form.  The 
ligand structures are pictured to the side of the associated spectrum. 
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ligands suggests that 3 is aggregating with the quadruplex in a non-specific manner, a 
situation that does not occur for 1.  When analyzed alone, both 1 and 3 show the same 
extent of dimer and trimer formation indicating that the differences seen in binding are 
not related to simple ligand aggregation (data not shown).  Results of the same 
experiment performed with 2 showed minimal binding even at ligand:DNA 
concentrations as high as 10:1, highlighting the impact of steric hindrance on DNA 
binding (data not shown). 
 
Figure 3.2  Fraction of bound DNA for ligands 1, 2, and 3 to quadruplexes, duplexes 
and single strands. Error bars represent standard deviations after three 
replicates each.  The ratio of ligand to DNA was 2:1 in each case. 
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Figure 3.3 ESI-mass spectra of Q2 (10 μM) with varying concentrations of 1 or 3.  
Concentrations of 1 were 20 μM (a), 50 μM (b) and 100 μM (c).  
Concentrations of 3 were 20 μM (d), 50 μM (e), and 100 μM (f). 
3.4.3 Interactions with Single-Stranded or Duplex DNA.   
To evaluate the selectivity of these ligands towards quadruplex DNA versus other 
alternative DNA structures, the ligands were incubated with single strand and duplex 
DNA.  The single strands or duplexes were chosen due to their widely different GC 
versus AT base content.  For instance, duplex DS1 contains over 80% GC base 
composition, whereas DS2 contains only about 25% GC base content.  A decrease in 
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binding of 1 to DS2 is expected if the binding is guanine specific.  Examples of the DNA 
binding results are shown in Figure 3.4 for DS1 with all three ligands.  It is evident from 
comparison of the ESI-mass spectra for solutions containing DS1 versus DS2 (data not 
shown) that 1 exhibited more substantial binding to the GC rich duplex than the AT rich 
duplex.  In fact, the extent of binding to DS2 was similar to that observed for the 
individual single strands for ligand 1 (see bar graph comparison in Figure 3.2).  This 
latter result suggests that the binding motif of 1 is G-selective but not necessarily 
uniquely specific for quadruplex or duplex structures.  In the case of 3, the ligand bound 
well to both duplexes and with a similar level of binding to both Q1 and Q2, thus 
indicating a greater degree of non-specificity with this ligand.  The bulky BOC group of 
ligand 2 suppressed binding to both duplexes.   
Examples of the ESI-MS binding results involving the single strands are shown in 
Figure 3.5.  Binding was lower for the single strands than for the duplexes or 
quadruplexes, even for the GC rich single strand.  The low level of binding to the single 
strands as well as the consistency across the three nucleoside ligands suggests that the 
single strand binding may be due to simple aggregation with no base specificity.   
The bar graph shown in Figure 3.2 summarizes the DNA binding trends for the 
three ligands and the various DNA structures.  The binding to guanine-rich 
oligonucleotides was most significant for 1 which is attributed to its three appropriately-
configured hydrogen-bonding sites.   As this ligand is designed with a donor-acceptor-
acceptor hydrogen-bonding pattern, it is complementary to the acceptor-donor-donor 
motif of Hoogsteen binding to guanine.  However, lack of any evidence of destabilization 
  
Figure 3.4  ESI-mass spectra of DS1 alone (a) and with 1 (b), 2 (c), or 3 (d).  DS 
indicates the double strand.   The duplex concentration was 10 μM and the 
ligand concentrations were 20 μM each. 
 43 
 
Figure 3.5  ESI-mass spectra of SS2 alone (a) and with 1 (b), 2 (c), and 3 (d). The single 




of the quadruplexes and duplexes upon binding of 1 would indicate that base stacking is a 
likely binding motif.  It is possible the pyrrole functionality enhances the binding to 
quadruplex and guanine rich duplex structures without disrupting the Hoogsteen or 
Watson-Crick interactions.  For 2, the single donor hydrogen-bonding site is blocked 
which, as reflected in Figure 3.2, greatly reduces the ability of 2 to bind to guanine in 
addition to causing substantial steric hindrance.  The steric hindrance factor is alleviated 
in the third ligand, 3; however, the lack of a donor hydrogen bonding site reduces its 
guanine specific binding affinity and makes it a less base-selective structural motif.   
3.4.4 Collision Induced Dissociation of DNA/1 Complexes.   
The nature of the binding interactions between ligand 1 and DNA was further 
explored by collision induced dissociation (CID).  Previous studies have shown that 
duplex/ligand complexes which incorporate groove binding interactions dissociate mainly 
by strand separation and base loss upon collisional activation, with some dependence on 
charge state32.  In contrast, elimination of the ligand upon CID conveys that the binding 
mode is intercalation32, 33. Our group and others have also reported different dissociation 
pathways for quadruplex/ligand complexes based on the binding mode10, 17, 23.  For 
quadruplex groove binders, strand separation either with or without base retention has 
been observed, while end-stacking ligands are typically ejected from the complexes17, 23.   
Dissociation of the Q2/1 complex resulted in loss of 1 rather than in strand separation 
(see Figure 3.6a), suggesting end-stacking as a possible binding mode. Dissociation of 
the -6 charge state of the DS1/1 complex resulted in loss of the ligand and no strand 
separation (see Figure 3.6b). While these CAD spectra cannot definitively confirm the 
binding mode, these dissociation patterns are consistent with intercalation or end stacking 
for the duplex and an end-stacking mode for the quadruplex.  
 
Figure 3.6  ESI-CAD mass spectra for Q2 and DS1.  The complexes dissociated were 




Ligand 1 bound two quadruplex structures, [dTG4T]4 and d(T2G4)4, as well as a 
guanine rich double strand.  Ligand 1, with the capability of forming three-point 
hydrogen bonds with guanine, was found to have high affinity for guanine-rich 
sequences, and binding was consistent with specific interactions with guanine bases.  The 
lack of aggregation of 1 with DNA at high concentration ratios supports that the binding 
is specific.  Only low abundance complexes were observed with 2, thus indicating the 
impact of steric hindrance caused by the large BOC blocking group.  Interactions 
between the various DNA structures and 3, especially at high ligand concentrations, 
indicate that this small ligand binds non-specifically.  In previous work undertaken in a 
predominantly organic solvent, evidence of dissociation of guanine nucleoside clusters 
upon addition of a water insoluble analog of 1 was interpreted as indicating the ability of 
this ligand to engage in Hoogsteen interactions that disrupted guanine-guanine binding28.  
Similar results were not explicitly seen in this work suggesting that the binding mode 
may be more complex.  For instance, CID spectra are consistent with end-stacking for the 
quadruplex/1 complex and intercalation as a possible binding mode for the DS1/1 
complex, which could explain the apparent guanine selectivity possessed by 1.  The 
differences in duplex binding between the three nucleosides may be due to the greater 
number of hydrogen-bonding sites of 1 or simply that the shape is sterically more 
conducive to intercalation than the others. This work showcases ESI-mass spectrometry 
as a tool for rapid screening of new synthetic ligands and its role in providing early stage 
feedback towards the design of base-selective DNA interactive ligands.     
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Chapter 4: Evaluation of Binding Selectivities and Affinities of 
Platinum-Based Quadruplex Interactive Complexes by Electrospray 
Ionization Mass Spectrometry 
4.1 OVERVIEW 
The quadruplex binding affinities and selectivities of two large π-surface PtII 
phenanthroimidazole complexes, as well as a smaller π-surface platinum bipyridine 
complex and a larger RuII complex, were evaluated by electrospray ionization mass 
spectrometry.  Circular dichroism (CD) spectroscopy was used to determine the 
structures of various quadruplexes and to study the thermal denaturation of the 
quadruplexes in the absence and presence of the metal complexes.  In addition, chemical 
probe reactions with glyoxal were used to monitor the changes in the quadruplex 
conformation due to association with the complexes.  The platinum phenanthroimidazole 
complexes show increased affinity to several of the quadruplexes with elongated loops 
between guanine repeats.  Quadruplexes with shorter loops exhibited insubstantial 
binding to the transition metal complexes.  Likewise binding to duplex and single strand 
oligonucleotides was low overall.  While the ruthenium-based metal complex showed 
somewhat enhanced quadruplex binding, the PtII complexes had higher quadruplex 
affinities and selectivities that are attributed to their square planar geometries.  The 
chemical probe reactions using glyoxal indicated increased reactivity when the platinum 
phenanthroimidazole complexes were bound to the quadruplexes, thus suggesting a 
conformational change that alters guanine accessibility.   
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4.2  INTRODUCTION 
 Throughout the development of platinum-centered complexes as DNA-interactive 
agents, the primary focus has traditionally been on covalent attachment rather than non-
covalent binding with one landmark example being the anti-cancer drug cisplatin.1  Other 
transition metal complexes, such as those based around RuII, have more often been 
designed to interact non-covalently with DNA, especially via intercalation.2-7  However, 
recent work has focused on creating non-covalent DNA interactive agents with PtII 
centers due to the relatively easy synthetic pathways as well as the different coordination 
geometry of platinum compared to ruthenium which extends the array of possible metal-
ligand architectures.8-10   
 The complexes of interest in the present work, phenylphenanthroimidazole 
ethylenediamine platinum(II) (2) and naphthylphenanthroimidazole ethylenediamine 
platinum(II) (3) (see Scheme 4.1), were developed specifically to interact with 
quadruplex structures.  Quadruplexes are a target of considerable biological interest due 
to their role in regulating the binding of telomerase.11-16  Telomerase lengthens telomeres, 
the G-rich sequences at the 3’ ends of DNA that allow replication or transcription to 
continue along the entire length of the strand.  When the telomere arranges into a 
quadruplex structure rather than remaining as an unfolded single strand, telomerase can 
neither bind nor lengthen the telomere.15, 17, 18  This prevents cells, more specifically 































phenanthroline) ruthenium (II) (4)
Scheme 4.1. Structures of metal complexes. 
 In order to increase quadruplex specificity, complexes 2 and 3 were designed with 
an extended aromatic π-surface area.19  Since PtII complexes form a square planar 
geometry rather than an octahedral geometry, such as that adopted by ruthenium 
compounds, the π-surface of these transition metal complexes is able to interact more 
effectively with the planar surface of the G-quadruplex.  In comparison to other platinum-
based complexes, these complexes have extended π-conjugated surfaces designed for 
optimal interaction with the G-quadruplex surface through size and electronic 
complementarity.    
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 In the past decade, electrospray ionization mass spectrometry (ESI-MS) has 
become a versatile tool for the study of non-covalent interactions.  In addition to 
examination of the interactions between proteins and small molecules or between 
proteins,20 mass spectrometry has been very useful for studying the non-covalent binding 
between oligonucleotides,21-31 between DNA and proteins,32-35 between DNA and small 
molecules,36-44 and between quadruplexes and  ligands.22, 28, 39, 45-54  Recently, the Ralph 
group has used ESI-MS and circular dichroism (CD) spectroscopy to probe the binding of 
ruthenium and platinum complexes to duplex and quadruplex oligonucleotides.7, 52, 55  It 
was determined that the small platinum complexes studied showed low binding affinities 
to quadruplexes in comparison to duplexes.52  This result is consistent with the prediction 
that large π-surface areas are necessary to enhance interactions with the G-quartet. 
 Recently, our group has begun using chemical probes in combination with ESI-
MS to study the impact of small molecule binding on oligonucleotide structure.56  Unlike 
traditional chemical probe techniques in which the outcomes of the reactions are 
evaluated using gel electrophoresis, our strategy uses mass spectrometry to monitor the 
extent of reaction with the chemical probe.  In addition, we have applied tandem mass 
spectrometry, including both collisionally induced dissociation (CID) and infrared 
multiphoton photodissociation (IRMPD), to determine the identity and location of the 
chemical probe reaction sites.  While our first efforts used potassium permanganate,57 
which oxidizes thymine bases, we are extending our mass spectrometric methods to other 
DNA-reactive chemical probes, specifically glyoxal in the present study.  Glyoxal has 
been used for traditional chemical probe analysis of both duplexes and quadruplexes.57-59  
Glyoxal is known to react with guanine bases at the N1 and N2 atoms,59 as illustrated in 
Scheme 4.2.   As these nitrogen sites are involved in hydrogen bonding between guanine 
bases in G-quadruplexes, they should exhibit reduced reactivity with glyoxal.  Moreover, 
any change in the secondary structure of a guanine-containing oligonucleotide upon 
binding of a ligand could change the accessibility of the active sites for reaction with 





































Scheme 4.2  Reaction between glyoxal and deoxyguanidine. 
 In this work, the relative DNA affinities of two established duplex intercalators, 
one a small PtII complex, 1, and the other a large RuII complex, 4, were compared to two 
novel complexes based on PtII centers, 2 and 3 (Scheme 4.1).  The latter two complexes 
have extended structures intended to facilitate binding to quadruplex DNA.  While the 
RuII complex is similar in size to the novel PtII complexes evaluated in the present study, 
the former has an octahedral geometry rather than square planar.  The square planar 
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geometry should increase the π-surface area available for interaction with the quadruplex, 
thus enhancing binding to the quadruplex.  Circular dichroism was used to determine the 
structure of the quadruplexes as well as to monitor changes in the melting points upon 
binding of the metal complexes.  ESI-MS was used to evaluate the relative binding 
affinities of the complexes to various oligonucleotide structures.  In addition, reactions 
with glyoxal were undertaken to assess the variation in reactivities of the guanine bases 
induced by interaction of the complexes with quadruplexes.   We present results that 
show that the novel complexes 2 and 3 have enhanced quadruplex selectivity over the 
smaller PtII and RuII complexes.    
4.3 EXPERIMENTAL. 
4.3.1 Materials.   
 Oligonucleotides were obtained from IDT DNA, Inc. (Coralville, IA) and used 
without further purification (see Table 4.1).  Quadruplexes and duplexes were annealed in 
150 mM ammonium acetate by placing the strands in a hot water bath and cooling to 
room temperature overnight (approximately 12 hours).   The DNA was annealed at 
concentrations to produce complexes in the range of 300-500 μM.  Thus, DS, Q2, Q3 and 
Q4 were all annealed at 500 μM while Q1 was annealed at 1.2 mM strand concentration.  
The annealed solutions were stored for at least 24 hours in the freezer before use.  
Although the conformations of the quadruplexes obtained for these annealing conditions 
are well mapped based on CD measurements, these are not necessarily the same 
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conformations as obtained in vivo. As the SS sequence has the potential to form 
homodimers or hairpins, non-denaturing gel electrophoresis was used to determine that 
the majority of the sample is in the single strand conformer under experimental 
conditions.  The PtII complexes were synthesized as discussed previously.19  All three 
complexes were dissolved to 1 mM in DMSO and stored in the refrigerator when not in 
use.  Glyoxal was purchased from Sigma-Aldrich (St. Louis, MO).    
Table 4.1  DNA sequences used in this work. 
















DS dGCGCGGAACCGCGC/ dGCGCGGTTCCGCGC duplex - 
SS dGCGCGGAACCGCGC single strand - 
*Assuming quadruplexes and duplex annealed in ammonium acetate.  
 
 The synthesis of bis(2,2’-bipyridine)(4,7-diphenyl-1,10-
phenanthroline)ruthenium(II) was carried out by first synthesizing bis(2,2’-
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bipyridine)ruthenium(II) chloride as described previously.60  One equivalent of 4,7-
diphenyl-1,10-phenanthroline was added to this precursor in 70% ethanol, and the 
mixture was refluxed for 30 minutes.61  TLC was performed to confirm that only one 
product was present, and the product was air dried.  The identity of the product was 
confirmed using MS.  As with the PtII complexes, the product (4) was dissolved in 
DMSO and stored in the refrigerator. 
4.3.2 Methods.   
4.3.2.1 ESI-MS 
 Three Thermo (San Jose, CA) ion trap mass spectrometers, an LTQ, an LCQ-
Duo, and an LCQ Deca modified for IRMPD,62 were used to perform ESI-MS.  For 
IRMPD, a 50W Synrad CO2 laser (Mukilteo, WA) was used to irradiate the samples 
through a hole in the ring electrode.  CID experiments were performed on the LCQ Deca 
instrument using an activation energy of 1.0 V and an activation time of 30 ms.  IRMPD 
experiments employed 99% laser power for 1.3 ms.   The ligands and oligonucleotides 
were combined in a 1:1 ratio, unless otherwise indicated, just before analysis.  To assist 
with desolvation and reduction of salt adducts, 20% methanol and 50 mM ammonium 
acetate was added to the samples immediately before analysis.  The DNA concentration 
for all ESI-MS samples was 10 μM. ESI-MS was performed in negative mode using a 
spray voltage of 3.5 kV with a heated capillary temperature of 90oC.  The tube lens 
voltage was varied between -150 and -250 V depending on the particular sample.  The 
percentage of bound DNA was calculated from the ESI mass spectra based on:   
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in which RAn:m indicates the relative abundances of the various DNA:metal complex 
products and RADNA corresponds to the relative abundance of the unbound DNA in the 
ESI mass spectra.40, 44   
4.3.2.2 CD 
 A Jasco J-815 circular dichroism system (Easton, MD) was used to collect 
circular dichroism spectra.  For melting point determinations, the CD signal, in mdeg, at 
293 nm was monitored as the temperature was increased from 25 to 90oC at a rate of 
0.2oC/minute.  The melting curve was imported into Origin 7.0 (OriginLab, 
Northampton, MA) for analysis.  The melting point, T1/2, was determined by fitting the 
data with a sigmoidal curve and determining the melting point from the inflection point.  
Oligonucleotide concentrations for CD were 5 μM.   
4.3.2.3 Chemical Probes 
 For the glyoxal reactions, 20 μM oligonucleotide complex in water was incubated 
with 0.5 μL glyoxal for 30 minutes at 37 oC.   For the experiments involving the DNA 
with the metal complexes, the metal complexes were added 10 minutes prior to glyoxal at 
a 2:1 complex to DNA ratio.  The samples were cleaned up using Pepclean C18 spin 
columns (Pierce, Rockford, IL) to remove excess glyoxal before analysis.   These 
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samples were analyzed by ESI-MS under similar conditions to those described above.  
Similar calculations to those described above to determine the percentage of bound DNA 
from ESI mass spectra were used to determine the extent of reaction with glyoxal, but 
RAn:m indicates the relative abundances of the glyoxal adducts rather than the relative 
abundances of DNA:metal complexes.   
4.4 RESULTS 
 A variety of experiments in both the gas phase and solution were undertaken to 
map the nature of the DNA/complex interactions. To determine the degree of structure-
specific binding of the metal complexes, a variety of DNA structures were studied.  
While it was expected that the metal complexes would show preference for quadruplex 
structures, quadruplexes have a range of orientations and sequences.   Four quadruplexes 
were used in this study:  Q1 (a tetramolecular quadruplex), Q2 (an antiparallel 
intramolecular quadruplex), Q3 (a parallel intramolecular quadruplex), and Q4 (an 
intramolecular quadruplex with a sequence consistent with the human telomeric repeat) 
(see representative structures in Scheme 4.3).  One guanine-rich duplex, DS, was studied 
as well, in addition to a guanine-rich single strand, SS, as representative models of other 
secondary structures.   ESI-MS was used to determine the percentage of bound DNA for 
the various samples to compare the relative binding affinities of the different metal 
complexes and, when used in conjunction with glyoxal reactions, to reflect changes in the 
secondary structure of the oligonucleotides upon binding of the metal complexes.  While 
ESI-MS results reveal insight into DNA binding (based on relative abundances and 
stoichiometries), CD results give a broader indication of the overall structure of the 











Scheme 4.3 Cartoons of quadruplex structures used in this work. 
4.4.1 CD spectroscopy of quadruplexes 
 Quadruplexes have specific CD signatures depending on the overall structure of 
the quadruplex.  For instance, an antiparallel intramolecular quadruplex has a peak at 295 
nm and a trough at 260 nm while a parallel quadruplex has a peak at 265 nm and a trough 
at 240 nm.63, 64  These features can be used to determine the structures of quadruplexes 
based on the CD spectra.  As expected, Q1 exhibits a peak at 266 nm and a trough at 243 
nm (Figure 4.1) which is consistent with a parallel quadruplex.  Both Q3 and Q4 yielded 
similar spectra to the tetramolecular quadruplex (Q1) indicating parallel conformations 
with positive peaks at 262 nm and troughs at 242 nm.  In the presence of sodium or 



































Figure 4.1  CD spectra of quadruplexes after annealing in 150 mM ammonium acetate. 
  
constituent oligonucleotides often result in the formation of antiparallel or mixtures of 
antiparallel and parallel quadruplexes.65, 66  In fact, when these sequences were analyzed 
without annealing, but were mixed with ammonium acetate added immediately before 
analysis, signature peaks are present for both parallel and antiparallel quadruplexes (data 
not shown).  It is only upon annealing these strands in ammonium acetate that the parallel 
conformation dominates.  The parallel conformation of similar quadruplexes, especially 
human telomeric sequence (Q4), has been observed with other annealing cations67, 68 as 
well as with ammonium.54  For parallel intramolecular quadruplexes,  the loops between 
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guanine repeats run diagonally across the sides of the quadruplex rather than over the top 
as is seen with antiparallel conformations.69  Q2 provided a very different CD spectrum 
with positive peaks at 292 and 242 nm and a trough at 259 nm.  This spectrum is 
characteristic of an antiparallel quadruplex structure.  The longer thymine loops between 
guanine repeats allows the loops to form over the top of the quadruplex rather than across 
the sides as occurs with the other two intramolecular quadruplexes.  Since complexes 2 
and 3 are designed to endstack with quadruplexes, both antiparallel and parallel 
intramolecular quadruplexes were included in our study to allow evaluation of the impact 
of the loop structure on the relative DNA binding affinities of the PtII complexes. 
4.4.2 Relative binding affinities and selectivities of metal complexes by ESI-MS 
 To determine the quadruplex selectivities of the PtII complexes, solutions 
containing equimolar concentrations of one of the four complexes and one of the four 
quadruplexes were analyzed by ESI-MS.  Examples of the resulting ESI mass spectra are 
shown in Figure 4.2, and the results are summarized in bar graph form in Figure 4.3.  
Based on the ESI-MS results and the calculated percentage bound values, Q2 exhibited 
very low affinity for the small complex, 1.    The percentage of bound Q2 increased by 
over an order of magnitude for the two PtII complexes, 2 and 3, with 2 more favored than 
3.   The RuII complex, 4, also showed a high degree of binding to Q2.   Interestingly, a 
comparison of the spectra obtained for Q2 with 2 and 3, shown in Figures 4.2b and 4.2c 
respectively, shows that a maximum of two molecules of 3 are bound to the quadruplex  
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Figure 4.2  ESI mass spectra of quadruplex Q2 with each metal complex.  The 
quadruplex:metal complex concentration ratio was 1:1.  The ion naming 
scheme involving denoting Q2 bound to one moiety of 2, for example, as 




































Figure 4.3  Percentage of bound DNA for each metal complex.  Each bar represents the 
average of three samples.  Refer to Scheme 4.1 for the structures of 
compounds 1-4. 
while only one molecule of 2 was bound.  While it is thought that both PtII complexes 
bind through the same mode of interaction, the ability of the larger complex to bind in a 
2:1 stoichiometry while the slightly smaller complex only binds in a 1:1 stoichiometry is 
intriguing and yet unexplained.  Both 1:1 and 2:1 stoichiometries are possible for an end- 
stacking binding mode since there are two ends at which the complexes can bind.  
Moreover, the small percentage of bound DNA observed for 1 is consistent with the prior 
results of the Ralph group that showed low binding of small platinum-centered 
complexes to quadruplexes.52 Similar trends in binding affinity were obtained for Q1, 
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which was also used in the previous study reported for these complexes although those 
results, obtained by UV-vis and equilibrium dialysis, showed greater binding for 3 than 
for 2.19  The abundances of complexes between Q1 and 2 or 3 were far greater than those 
of Q1 with 1, with binding to 2 slightly favored.   
 Surprisingly, quite different results were obtained for the two parallel 
intramolecular quadruplexes (Q3 and Q4).  The percentage of bound DNA for both Q3 
and Q4 was found to be 10% or less for each of the four complexes.  These results 
suggest that the geometry of the loop regions with these quadruplexes defines the 
potential binding interactions with the complexes.  The free thymine bases on the ends of 
the intermolecular quadruplex (Q1) and the arching loops of the antiparallel 
intramolecular quadruplex (Q2) both facilitate favorable binding between the complexes 
and the quadruplexes.  However, the shorter loops that result in a parallel conformation 
for the intramolecular quadruplexes (Q3 and Q4) restrict binding with the complexes and 
result in low abundances for the quadruplex/metal complex species.  These loops are 
suggested to run diagonally across the sides of the quadruplex rather than over the top69 
which may diminish complex binding to the quadruplex.  This structure-based 
suppression of metal complex binding is further supported by the slight increase in 
binding of 2 to Q4 over Q3 because Q4 has one more nucleotide between guanine repeats 
which may result in less strained outer tetrads as the extra nucleotide provides greater 
length to transverse the quadruplex.    
 To assess the degree of complex selectivity for quadruplexes versus other DNA 
structures, ESI mass spectra were acquired for solutions containing an equimolar mixture 
of a guanine-rich duplex (DS) or guanine-rich single strand (SS) and each of the metal 
complexes.  The resulting mass spectra are shown in Figure 4.4, and the results are 
summarized in Figure 4.3 to allow easier visual comparison to the quadruplex results.   
There was minimal binding to the single strand for all complexes and slightly greater 
binding to the duplex.  Complex 1 resulted in a higher percentage of bound DNA for the 
 






















































































































Figure 4.4  ESI mass spectra of DS and SS with each metal complex.  The 
concentration ratio of metal complex to DNA is 1:1. 
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duplex compared to the four quadruplexes or single strand, thus supporting its greater 
affinity for duplex DNA.  The other three complexes, 2, 3, and 4, all exhibit selectivity 
for interaction with quadruplexes over the duplex or single strand DNA.   
 Additional experiments were undertaken in which the concentration ratio of 
complex to DNA was 2:1 rather than 1:1 (data not shown).  While higher concentration 
ratios were not studied due to salt contaminants in the complexes resulting in 
uninterpretable mass spectra, the additional complexes present allow more extensive 
evaluation of the potential stoichometries of each complex with DNA.  With SS and DS, 
in addition to an overall increase in the percentage of bound DNA, 2 and 3 showed low 
abundances of 2:1 complexes not seen in the spectra acquired with the 1:1 concentration 
ratio of complex to DNA.  Binding with Q3 was similar to that of the 1:1 concentration 
solutions, with low abundance products with all metal complexes, while the spectrum of 
2 with Q4 showed a marked increase in the percentage of bound DNA as well as a low 
abundance 2:1 product.  The greatest changes in product formation were seen for the Q1 
and Q2 quadruplexes.  The percentage of bound DNA increased and additional higher 
order products were observed between both of these quadruplexes and 2 and 3.  2 formed 
2:1 complexes with both Q1 and Q2, whereas3:1 complexes were observed with 3 and 
both Q1 and Q2.  The 3:1 complexes of 3 with Q1 and Q2 are surprising since an end-
stacking binding mode would only account for association of two molecules of 3 with the 
quaduplexes.  It is possible that the additional 3 is interacting along the side of the 
quadruplex or two 3 moieties might stack on one another, but there is no specific 
evidence supporting either hypothesis.  When analyzed alone by ESI-MS, 3 did not form 
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aggregates, but the planarity of the structure might permit stacking.  The other metal 
complexes, 1 and 4, showed a minimal increase in the percentage of bound DNA for 
either Q1 or Q2.   
4.4.3 Reactions of glyoxal with DNA and DNA/metal complexes 
 In order to monitor the perturbation of the DNA structures upon non-covalent 
binding of the metal complexes, chemical probe reactions were undertaken in conjunction 
with mass spectrometric analysis.   As discussed in the experimental section, solutions 
containing DNA or DNA with one of the metal complexes were incubated with glyoxal, 
followed by clean-up with C18 spin columns. Glyoxal reacts at guanine bases, thus 
serving as a chemical probe of accessible guanines.60  To confirm that thymine bases are 
unreactive with glyoxal, a 6-mer sequence containing only thymines was reacted under 
the same conditions as the other strands.  The results (not shown) indicate that no reaction 
occurs.  Initial experiments involving the duplexes or quadruplexes in the absence of 
metal complexes indicated the loss of secondary structure of the DNA after the 
glyoxal/clean-up procedure based on the detection of only single strand oligonucleotides 
in the mass spectra.  To determine whether this disruption of secondary structure was due 
to heating during the reactions or to the C18 clean-up procedure, samples of DS and Q1 
were analyzed by ESI-MS before heating, after heating at 37o C, and after C18 sample 
clean up, in each case without the presence of glyoxal.  The results (not shown) 
confirmed survival of the duplexes and quadruplexes both before and after heating.   
However, after the C18 clean-up procedure, intact quadruplexes or duplexes were no 
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longer detected by ESI-MS.  This series of results indicates that the loss of secondary 
structure occurs during the C18 clean-up and is not a confounding result of the glyoxal 
reactions.  This means that ESI-MS can be used to monitor the impact of the metal 
complexes on the DNA reactivity with glyoxal based on detection of glyoxal adducts of 
the constituent DNA sequences.  Typical ESI mass spectra are shown in Figure 4.5.  
  As expected, SS, with its less rigid secondary structure, proved the most reactive 
with glyoxal (Figure 4.5a).  The guanine bases are not blocked by intramolecular 
hydrogen bonds or bonds with other guanines or cytosines, thus leaving them more 
accessible to reaction with glyoxal.  Up to four glyoxal moieties were observed bound to 
the single strand.  The reactivity of DS with glyoxal is approximately two times lower 
than that of SS (data not shown), and a maximum of two glyoxal moieties are bound to 
the strands.  Hydrogen bonding between the guanine bases and complementary cytosine 
bases apparently suppresses the reactions with glyoxal.   
Q1 was chosen for the glyoxal studies because, as an intermolecular quadruplex, 
the reactions of its constituent sequence (as a single strand) can be studied in parallel to 
the reactions of the quadruplex.  CD spectra of the intramolecular quadruplexes (Q2, Q3, 
and Q4) indicated that, even without prior annealing, these strands fold into quadruplex 
structures.   Parallel reactions with the single strand conformer permit the separation of 
the impact of the interstrand hydrogen bonding from that of the metal complexes  on 
glyoxal reactivity, a distinction that would not be possible with an intramolecular 
quadruplex.  To that end, reactions of Q1 and its constituent single strand (Q1ss) with 
glyoxal were undertaken, and the resulting ESI-MS data are shown in Figures 4.5b and c.  
While Q1ss was approximately half as reactive as SS, the latter which contains six 
guanine bases compared to four guanines in Q1ss, its substantial reactivity with glyoxal 
confirmed the significant accessibility of its guanines.  The reactivity of Q1 with glyoxal  
 






























































Figure 4.5  ESI mass spectra of DNA after reaction with glyoxal.  Spectra were 
collected for (a) SS, (b) Q1ss, and (c) and Q1.  Q1ss corresponds to the 
single strand form of Q1 that was not annealed.  As discussed in the text, the 
quadruplex Q1 disassembles during C18 clean-up procedure resulting in 
detection of the single strand Q1ss.  Glyoxal adductions are noted by X. 
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decreased by a factor of four relative to that of Q1ss, presumably because the Hoogsteen 
hydrogen bonds between the guanine bases of Q1 block access to and/or suppress 
reactions of glyoxal.  
 Figure 4.6 summarizes the results of similar glyoxal reactions performed after Q1 
was incubated with each of the metal complexes.  The extent of reaction with Q1 is 
calculated from the ESI mass spectra in a similar manner to that used to quantify the 
percentage of bound DNA for solutions containing DNA and the metal complexes.  In 
this case, the abundances of all of the glyoxal-adducted DNA ions were summed and 
divided by the summed abundances of the all DNA species (both unreacted DNA and the 
DNA/glyoxal adducts) and then converted into a percentage.   It should be noted that the 
quadruplexes and other non-covalent interactions were disrupted during C18 clean-up of 
the glyoxal-containing mixtures.  The results summarized in Figure 4.6 reflect the extent 
of reaction based on detection of single strand products even when target DNA was 
annealed into a quadruplex form prior to incubation with the metal complexes and 
subsequent reactions with glyoxal.  In other words, the extent of reaction of Q1 shown in 
Figure 4.6 is based on reaction with glyoxal of the same number of guanines as the extent 
of reaction with Q1ss.  Interaction of the quadruplex with 1 caused minimal change in the 
reactivity of the quadruplex.  However, interaction with 2 increased the extent of reaction 
with glyoxal by a factor of two.   This result is an indication that 2 alters the structure of 
the quadruplex in such a way that increases the accessibility of some of the guanine 
bases.  Similarly, 3 also increases the extent of reaction of the quadruplex with glyoxal, 
although to a lesser extent than 2.  These data are consistent with the trend in relative 
binding affinities discussed earlier in which a higher percentage of bound DNA was 
found for 2 over 3. Comparable to 1, 4 did not cause a change in the extent of reactivity 
of the quadruplex with glyoxal compared to the free quadruplex.  Despite the large size of 
the ligand, the RuII complex 4 itself does not appear to cause the same structural changes 































Figure 4.6  Summary of the extent of reaction with glyoxal for Q1ss, Q1 and Q1 in the 




interaction or different binding mode between 4 and Q1 than 2 or 3.  The possibility of 
cross-reactivity of glyoxal with the metal complexes themselves, a process that would 
sequester the complexes and intervene with binding, was also considered.  There was no 
evidence to support the occurrence of this cross-reaction.   
The reactions of glyoxal with the double strand, DS, both in the absence and 
presence of the metal complexes, were also evaluated by ESI-MS (data not shown).  
Based on the abundances of the DNA/glyoxal adducts, the differences in the reactivity of 
glyoxal with the free duplex or with the duplex bound to the metal complexes were 
determined to be negligible. This finding suggests that the metal complexes do not cause 
a significant change in the structure of the duplex, either in terms of blocking reaction 
sites or by unwinding the duplex.   
4.4.4 Tandem mass spectrometry of glyoxalated quadruplexes 
 Tandem mass spectrometry via collision induced dissociation (CID) and infrared 
multiphoton dissociation (IRMPD) was used to examine the structures of the 
DNA/glyoxal adducts and determine the specificity of the glyoxal reaction sites.  
Examples of the resulting mass spectra are shown in Figure 4.7 for the Q1ss/glyoxal 
adducts in the 3- charge state.   Upon CID, the most abundant product ion stemmed from 
loss of the glyoxal moiety (Figure 4.7a).  Dehydration of the Q1ss/glyoxal adduct, as well 
as loss of either a guanine base (e.g. [M – G]3-) or a glyoxal-modified guanine base (M – 
(G + glyoxal)]3-), were also dominant fragmentation pathways.  These channels are not 
useful for identifying the specific location of the glyoxal reaction site.  Upon IRMPD, 
there was more extensive cleavage of the DNA backbone, resulting in both (a – B) and w 
fragment ions that retained the dehydrated glyoxal modification (Figure 4.7b).  The 
majority of these (a – B) and w ions stem from cleavages that occur adjacent to guanine 
bases.  Product ions ranging from a5 to a8 and w5 to w7 were found to retain the 
dehydrated glyoxal moiety.  This array of diagnostic sequence ions indicates that the 
glyoxal reaction occurs non-specifically at different guanine sites rather than localizing at 
specific guanine bases.  The IRMPD mass spectra acquired from the samples containing  
 
Figure 4.7  Dissociation of [Q1ss + glyoxal]3-  by (a) CID  at 1.0 V activation energy 
and (b)  IRMPD at 99% laser power for 1.3 ms.  Ions that include the 




the quadruplex Q1 in the presence of each of the metal complexes were similar, 
indicating that the metal complexes do not appear to activate or suppress the glyoxal 
reaction at uniquely identifiable guanines.   
4.4.5 T1/2 of Q2 and metal complexes 
 Relative comparison of quadruplex melting points (T1/2 values) in the presence 
and absence of DNA-interactive ligands can be used to assess how the ligands affect the 
stabilities of the quadruplexes.  An increase in the melting point of a quadruplex upon 
binding of a ligand suggests an increase in stability against thermally stress.  The Q2 
quadruplex was chosen for melting point analysis because it produced the most abundant 
complexes with 2 and 3 by the ESI-MS analysis.   In this case, Q2 was analyzed in the 
presence and absence of the four metal complexes.  The melting and cooling curves of 
the quadruplex did not overlap, indicating the quadruplex was not at equilibrium (data not 
shown).  Although this implies that the melting points are not the true equilibrium 
melting points and should not be used for thermodynamic calculations, the results are still 
useful for these simple relative comparisons of thermal stability70.  In fact, it is common 
for quadruplexes in general71 and this sequence in particular72 to have slow 
association/dissociation kinetics that result in hysteresis between the melting and 
annealing curves even at very low heating and cooling rates.  Quantitative results are not 
critical for this work, and the values given for T1/2 are useful for relative comparisons. 
 Without the presence of a metal complex, the Q2 quadruplex yielded a T1/2 value 
of 50.3 oC (Table 4.2).  The addition of 1 caused an insignificant increase in the T1/2 (50.5 
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oC). In addition, 4 only increased the T1/2 of Q2 by approximately 4o C (to 54.1 oC).  In 
comparison, 2 increased the melting temperature 18o C, thus indicating a greater degree 
of stability against thermal denaturation.  Moreover, the addition of 3 caused the greatest 
increase in the T1/2 to 72 oC.   As was shown above, in comparison with 2, 3 exhibited 
slightly lower binding affinities to quadruplexes based on the ESI-MS results.  However, 
the protection of Q2 against thermal denaturation by 3 here is greater than 2.  The larger 
size of the ligand in this metal complex appears to stabilize the quadruplex to a greater 
extent than 2, perhaps indicating a higher binding avidity, despite the slightly lower 
binding affinity estimated from the ESI-MS results.  It is also possible that 3 is forming 
higher order adducts with the DNA than 2, as is suggested by the ESI-MS results 
obtained for the 2:1 metal complex:DNA solutions.  








Q2 50.3 ± 0.2 - 
Q2 + 1 50.5 ± 0.2 0.2 
Q2 + 2 68 ± 1 18 
Q2 + 3 72 ± 1 22 




 The combination of large, planar ligands attached to the PtII core appears to 
provide better quadruplex interaction than complexes that have small ligands or are based 
around a metal with the RuII octahedral geometry.  Thermal denaturation studies and 
reactions with glyoxal in the presence of the four metal complexes also show that 2 and 3 
afford increased thermal stability over the other complexes, as well as induce changes in 
guanine accessibility in the quadruplexes.   While showing relatively high affinities for 
Q1 and Q2, 2, 3 and 4 exhibited much lower binding to Q3 and Q4.  This striking 
difference in binding of the complexes highlights the importance of quadruplex structure.  
As end-stacking binders, these metal complexes are sensitive to the secondary structure 
surrounding the quadruplex.  It should also be reiterated that Q4, in the presence of 
sodium and potassium, often forms antiparallel or mixed orientation quadruplexes rather 
than parallel quadruplexes.  This could permit binding similar to that seen for Q2 to occur 
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Chapter 5: ESI-MS Characterization of Doxorubicin and Daunorubicin 
Binding to Mismatches in Hairpin Oligodeoxynucleotides 
5.1 OVERVIEW 
 Doxorubicin and daunorubicin, non-covalent DNA binding ligands, were studied 
to determine how binding was affected by the presence of one or more mismatched base 
pairs.  Three hairpin oligodeoxynucleotides were studied: one with a wild type sequence, 
one with one base pair mismatch, and one with two base pair mismatches.  At or near 
equimolar concentrations, both ligands showed a preference for binding to the 
mismatched oligodeoxynucleotides.   
5.2 INTRODUCTION 
 Electrospray ionization (ESI) allows the transfer of non-covalent complexes from 
solution to the gas-phase, thus facilitating the analysis of many types of biological 
complexes by mass spectrometry.  This permits the study of duplex1-3, triplex4, and 
quadruplex4-10 DNA structures, as well as the determination of binding selectivities, 
stoichiometries, and binding affinities of metal-mediated DNA complexes,11, 12 
DNA/protein complexes13, 14, and other DNA/ligand complexes.11, 15-20  In the present 
work, the complexation of anthracycline ligands, doxorubicin (DOX) and daunorubicin 
(DAU) (Scheme 5.1), with three hairpin oligodeoxynucleotides was evaluated by ESI-
MS.  The hairpins used in this work are based on the iron responsive elements (IREs) in 
mRNA.  It has previously been shown that anthracycline ligands bind to IREs21, and that 
this binding might be partially responsible for the cardiotoxicity that limits clinical use of 
anthracyclines22.  The hairpins consisted of a wild type control sequence, a second 
sequence containing a cytosine to thymine mutation, and a third sequence containing two 
cytosine to thymine mutations.  ESI-MS was used to determine the binding specificity of 












DAU: X=H  
Scheme 5.1 Structures of anthracycline ligands doxorubicin (DOX) and daunorubicin 
(DAU). 
5.3 EXPERIMENTAL 
 DOX and DAU were dissolved in DMSO to various stock concentrations (from 
10 mM to 100 μM).  The hairpins, with sequences shown in Table 5.1, were annealed in 
BPE buffer by cooling the samples overnight from 90oC to room temperature.  Annealed 
samples were stored in the freezer.  Each annealed hairpin (10 μM) was incubated with 
the desired concentration of the appropriate ligand for 20 minutes in the refrigerator to  
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Table 5.1 Sequences of oligodeoxynucleotides used in this work. 
Name  Sequence  
WT  5’-GCCTCCAAATCTTGGAGGC-3’  
6  5’-GCCTCTAAATCTTGGAGGC-3’ 
D  5’-GCCTCTAAATCTTGGAGGC-3’ 
 
allow for equilibration, and then 50 mM ammonium acetate was added prior to ESI-MS 
analysis to assist with desalting.  ESI-MS was performed on a Thermo Scientific (San 
Jose, CA) LTQ-XL linear ion trap mass spectrometer.  The source conditions were 
optimized to minimize disruption of the hairpin/ligand complexes by maintaining the 
capillary temperature at 90oC and source voltage at 3.5 kV.  The tube lens voltage was set 
to -150 V, and all analyses were performed in the negative mode.  The extent of DNA 
binding is expressed as a “relative binding percentage”. For the calculation of relative 
binding percentages, peak areas were determined using Origin 7.0, and the peak areas of 
all hairpin/ligand complexes were summed and divided by the summed peak areas of all 
DNA species as shown in this equation: 
  % / / /
/ / /
100              (Eq. 5.1) 
where PAHP is the peak area of the free hairpin and PAHP/Ln are the peak areas of the 
complexes containing each hairpin bound to n ligands.  Higher values of the relative 
binding percentages indicate greater hairpin/ligand binding affinities.  Three replicates 
were undertaken for each solution. 
5.4 RESULTS AND DISCUSSION 
After incubation of each hairpin with each ligand, the resulting solutions were 
analyzed by ESI-MS.  Hairpin/ligand complexes were abundant and easily identified in 
the resulting ESI-mass spectra.  As an example, Figure 5.1 shows an ESI mass spectrum 
of hairpin WT in the presence of 5 μM DOX (i.e. a 2:1 hairpin: ligand concentration 
ratio).  Complexes containing up to two DOX ligands bound to the hairpin are observed.  
The oligodeoxynucleotides and complexes tend to have slightly higher levels of salt 
adduction than are normally observed by ESI-MS due to the presence of the BPE buffer. 
  
Figure 5.1 Negative mode ESI mass spectrum of WT (10 mM) in solution with DOX 
(5 mM).   













































































































Figure 5.2 Charts comparing relative binding  percentages for the three hairpins WT, 6, 
and D with the ligands DOX (a) and DAU (b).   
The relative binding affinities of the ligands to each hairpin were calculated 
according to Equation 5.1 based on integration of peak areas of the various complexes 
and unbound hairpin in the ESI mass spectra for each incubate.  The results are 
summarized in Figure 5.2 over a range of ligand concentrations (and a constant hairpin 
concentration of 10 μM) until virtually saturated at 20 μM ligand.  As expected, the 
relative binding increase percentages increase with increasing ligand concentration.  
Comparison of the relative binding percentages for DOX concentration ranging from 1 to 
10 μM indicate that DOX exhibits greater binding affinities for the mismatched hairpins 
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6 and D compared to the WT hairpin.  The differences were significant to a 95% 
confidence interval in most cases.  For the solutions containing the greater ligand 
concentrations (20 and 50 μM DOX), the relative binding percentages were similar for all 
three hairpins, suggesting that there is a significant degree of non-specific binding at 
higher ligand concentrations.  Similar trends were observed for DAU (Figure 5.2b).  As 
with DOX, the binding affinities for the mismatched hairpins 6 and D were greater than 





































Figure 5.3 Chart of normalized relative binding percentage for each hairpin:ligand 
stoichiometry for WT bound to DOX.   
 The stoichiometries of the hairpin/ligand complexes were also evaluated by ESI-
MS for solutions containing 10 μM hairpin and 0.1 to 50 μM ligand.  The relative 
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distributions of complexes containing one hairpin and from one to five ligand molecules 
are plotted in Figure 5.3.  At the lowest ligand concentration, only 1:1 complexes were 
formed.  However, once the ligand concentration is increased to 1 μM or greater, 1:2 
hairpin:ligand complexes are observed, and even higher order complexes (1:3, 1:4, and 
1:5 hairpin:ligand complexes) are detected for solutions containing greater ligand 
concentrations. The dominance of the 1:1 complexes and to a lesser extent 1:2 complexes 
is likewise observed for the majority of the hairpin solutions containing WT, 6 or D and 
either DOX or DAU.   
5.5 CONCLUSIONS 
 ESI-MS allows ready detection of the hairpin/ligand complexes, and comparison 
of the relative binding percentages confirms that the ligands exhibit higher affinities for 
the mismatched hairpins than the wild type hairpin.  The difference in binding affinities is 
most notable for solutions containing nearly equimolar concentrations of the hairpin and 
ligand.  At greater ligand concentrations, higher order complexes are observed which 
signal the occurrence of non-specific interactions that suppress the selective binding of 
the ligands to the mismatched hairpins.   
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Chapter 6: Covalent Cross-links of DNA by RH1 and RH1 Derivatives 
Studied by LC-IRMPD-MS 
6.1 OVERVIEW 
 Two aziridinylbenzoquinone-based DNA cross-linking agents were studied by 
LC-MS/MS to determine their relative abilities to cross-link oligodeoxynucleotides with 
different target sequences.  RH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-methyl-1,4-
benzoquinone), a clinically studied anti-tumor cross-linking agent was compared to a 
similar molecule that had been modified with a phenyl group rather than a methyl group.  
The bulky phenyl substituent was added to determine how steric hindrances would affect 
the ability to form cross-links in a double helical structure.  Cross-links formed by RH1 
and PhRH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-phenyl-1,4-benzoquinone) were 
observed at 5’-dGNC sites as well as 5’-dGAAC/dGTTC sites.  RH1 was more effective 
at forming cross-links than PhRH1 with all strands. IRMPD and CID results confirmed 
the presence and the location of the cross-links within the duplexes, and IRMPD was 
used to identify the dissociation pathway of the cross-linked duplexes.    
6.2 INTRODUCTION 
 DNA interactive anti-tumor agents can function through non-covalent 
interactions, such as intercalators1, 2 and minor groove binders,3, 4 or through covalent 
modifications of the nucleobases.5-9  In many cases, the mechanism of action is to alter 
the structure of DNA sufficiently that replication machinery does not recognize relevant 
binding sites, preventing proliferation,10, 11 or the cellular apoptosis pathway is 
 94 
triggered.12, 13  While interstrand cross-links occur relatively infrequently in comparison to 
monoadducts or intrastrand cross-links, the greatest cytotoxic effects of many anti-tumor 
agents are thought to be based on the formation of key interstrand cross-links.14-17  While 
cross-links can vary greatly in size and position, a major mode of cytotoxicity is the 
prevention of strand separation during replication.16 
 As anti-tumor agents are designed to prevent cells from replicating, ideally they 
should exhibit a high level of specificity for tumor cells to prevent widespread death of 
healthy cells.  Bio-reductive agents use the cellular environment of tumor cells to provide 
specificity.18-20  Bio-reductive agents enter the cell in an inactive, oxidized form and are 
reduced by enzymes within the cell to become cytotoxic.  This reduction is optimized 
under the hypoxic conditions which are frequently found in tumor cells.19  The most well 
studied of these is mitomycin C which covalently binds two guanine bases after chemical 
or enzymatic reduction.21-23   Formation of monoadducts and both interstrand and 
intrastrand cross-links are possible for mitomycin C with monoadduction being the 
dominant type of DNA modification.22, 23  Mitomycin C has been studied extensively and 
used clinically in the treatment of many cancers including bladder,24 colorectal,25, 26 and 
gastrointestinal,27 among others.19, 28-32  Other bioreductive compounds have also been 
developed including nitroaromatics, aliphatic N-oxides, and heteroaromatic N-oxides.18  
All of these types of compounds are reduced by a variety of cellular reductases before 
becoming biologically active.  The types of interactions between the activated 
compounds and DNA can range from non-covalent intercalation to cross-link formation.18   
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 Another class of bioreductive agent is based on the quinone moiety.  For example, 
benzoquinones with bifunctional mustard moieties have been found to cross-link DNA 
and the efficiency of the reaction is based upon the other quinone substituents.33-35  
Aziridinylbenzoquinones contain aziridine rings that react with DNA upon conversion of 
the quinone moiety to the hydroquinone.36  The reduction to the hydroquinone increases 
the pK of the aziridine groups, thus allowing the alkylation reaction to occur at 
physiological pH.  Several of these ligands have been found to react with DNA, and the 
reactivity has been shown to be extremely sensitive to the other substitutions on the 
quinone.36-39  One of these agents, RH1, has been studied clinically for its anti-tumor 
properties.39  Most recently, it was evaluated for possible use as a chemotherapeutic drug 
for childhood cancers including neuroblastomas, osteosarcomas, and Ewing’s scarcoma.40  
The two aziridine rings allow cross-linking of guanines via the N7 atoms, and the methyl 
and hydroxymethyl substituents have been found to support cross-linking specifically at 
5’-dGNC sequences36 (Scheme 1).  The presence of the cytosine in this segment ensures 
that this guanine will be in close proximity to a guanine on the opposite strand.   
 Mass spectrometry has proven to be a versatile tool for characterization of both 
covalent and non-covalent interactions of ligands with DNA and cross-links in particular.  
Traditional techniques for analyzing DNA adducts, such as NMR41, 42 or gel 
electrophoresis methods,43, 44 are time consuming and typically have lower sensitivity than 
mass spectrometry.  A variety of DNA binding characteristics can be determined using 










































Scheme 6.1 Reduction mechanism and possible cross-link structure for RH1.  Adapted 
from ref. 36.   
stoichiometries and sequence affinities of DNA interactive ligands can be determined by 
using ESI-MS.45-53  In some cases, the binding mode of non-covalent interactions can be 
determined through tandem mass spectrometry.54  In addition, chemical probes in 
conjunction with dissociation techniques can be used to map the sites of DNA/ligand 
interactions.55  Ion activation/dissociation techniques can be used to identify the site of 
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reaction for covalently bound ligands56 and can also be used to characterize the actual 
atomic linkages between the ligand and the DNA.57-59  Coupling tandem mass 
spectrometry with HPLC as a front-end separation technique, complex samples 
containing very low levels of covalent cross-links and adducts can be studied.60-62  These 
techniques have been used both with small oligodeoxynucleotides56, 63 as well as with 













Figure 6.1 Aziridinylbenzoquinones.   
 In this work, two azirdinylbenzoquinone ligands (Figure 1) will be studied to 
characterize their cross-linking ability with several duplex oligodeoxynucleotides.  The 
cross-linking efficacy of a phenyl derivative of RH1, PhRH1 in which a methyl group is 
replaced by a phenyl group, is compared to the cross-linking ability of RH1 to determine 
the effect of the phenyl substituent on binding and cross-linking.  The bulky phenyl group 
is expected to cause greater steric hindrance to both reduction and to cross-linking which 
would limit the overall activity.  Comparing the abilities of the two ligands to cross-link 
 97 
 98 
various duplexes affords insight into how the quinone substituents modulate the reactivity 
of the ligands.  Further characterization by IRMPD-MS provides information on the 
location of the cross-links within the oligodeoxynucleotides. 
6.3 EXPERIMENTAL 
6.3.1 Materials 
 Oligodeoxynucleotides, as listed in Table 1, were purchased from IDT DNA, Inc. 
(Coralville, IA) and resuspended in HPLC grade water.  RH1 was synthesized as 
previously described.39, 65 The phenyl derivative, PhRH1, was custom synthesized.  
Ammonium acetate, HPLC grade water, and HPLC grade acetonitrile were purchased 
from Fisher Scientific (Pittsburgh, PA).  Sodium acetate was purchased from EM Science 
(Gibbstown, NJ).   
6.3.2 Methods 
6.3.2.1 Annealing  
 Duplexes were created from two complementary oligodeoxynucleotides that were 
annealed in 150 mM ammonium acetate by placing the oligodeoxynucleotides in a 90oC 
water bath and allowing the two strands to cool overnight to room temperature, over 




Table 6.1 Oligonucleotide sequences used in this work  
Name  Sequence  
DS1  a: 5’-ATATAGCCTATAT-3’ 
b: 3’-TATATCGGATATA-5’ 
DS2  a: 5’-AAATATGACTATAT-3’ 
b: 3’-TTTATACTGATATA-5’ 
DS3  a: 5’-AAATTGAACAAATT-3’ 
b: 3’-TTTAACTTGTTTAA-5’ 
DS4  a: 5’-GACAAATTGACATA-3’ 
b: 3’-CTGTTTAACTGTAT-5’ 
DS5  a: 5’-TAGACATAGAACAA-3’ 
b: 3’-ATCTGTATCTTGTT-5’ 
DS6  a: 5’-ATATACGTATAT-3’ 
b: 3’-TATATGCATATA-5’ 
DS7  a: 5’-AAATATGCATATAT-3’ 
b: 3’-TTTATACGTATATA-5’ 
DS8  a: 5’-AATTAATTAATTAA-3’ 
b: 3’-TTAATTAATTAATT-5’ 
 
6.3.2.2 Reduction/cross-linking reaction  
 Approximately 2 μmol RH1 or PhRH1 was placed in a conical vial.  For RH1, 
100 μl of 100 mM sodium acetate (pH 6) was added along with 6.5 nmol of annealed 
duplex DNA.  The same conditions were used for PhRH1, with the exception that PhRH1 
was dissolved in 20 μl of DMSO before the addition of the sodium acetate.  The solution 
containing the quinone ligand and the duplex oligonucleotide was placed in an ice bath 
with argon bubbled through it.  In a separate flask, an approximately 0.5 M solution of 
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sodium hydrosulfite in 100 mM sodium acetate (pH 6) was also kept on ice and under 
argon.  Two 20 μl aliquots of the sodium hydrosulfite solution were added to the 
quinone/duplex solution 25 minutes apart.  Overall, the reaction took fifty minutes.  The 
solution was then exposed to air. Following the reaction, each quinone/duplex solution 
was desalted using a 3 kDa molecular weight cutoff filter (Amicon Ultra, Millipore, 
Billerica, MA) followed by a 0.22 μm Durapore filter (Amicon Ultrafree-MC, Millipore, 
Billerica, MA).   
6.3.2.3 LC-MS   
 The desalted solutions were analyzed by capillary LC-MS.  A Dionex (Sunnyvale, 
CA) Ultimate 3000 capillary HPLC system fitted with a 0.3 X 150 mm Zorbax 300SB-
C18 column (5 μM particle size, Agilent, Santa Clara, CA) was used for the separation.  
The aqueous mobile phase (A) was 10 mM ammonium acetate and the organic mobile 
phase (B) was 50% 10 mM ammonium acetate/ 50% ACN.  The gradient elution method 
varied depending on the sequences of interest, but the general method involved a gradient 
from 99% A to 85-80% A over 38 minutes.  The flow rate was 4 μl/min.  The LC system 
was directly coupled to a Thermo Scientific (San Jose, CA) LTQ XL linear ion trap mass 
spectrometer.  The mass spectrometer was operated in the negative ESI mode and the 
capillary temperature was set to 120οC.  The system had been modified for IRMPD by 
the addition of a zinc selenide window at the back of the instrument as described 
previously.66  IRMPD was achieved using a Synrad (Mukilteo, WA) 50W CO2 laser at a 
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wavelength of 10.6 μm.  For these experiments, the laser power was set to approximately 
10 W, and the laser was triggered during the activation step for 2 to 10 ms.   
6.3.2.4 Relative quantitation   
 To determine the relative cross-linking efficiencies of the quinones with the 
duplexes, peak areas were determined from the UV chromatogram.  The UV 
chromatograms were used for relative quantitation to alleviate discrepancies due to 
variable DNA ionization efficiencies from the results.  The peak areas for the cross-
linked duplexes were divided by the summed peak areas of all DNA species, including 
both cross-linked DNA and unmodified single strands, as shown in the following 
equation 
 
   %     (1) 
 
where PACL is the peak area of the cross-linked duplex and PAssa and PAssb refer to the 
peak areas of each of the unmodified single strands.  Each peak area was normalized with 
the molar extinction coefficient for the corresponding oligonucleotide sequence, εa or εb.  
For the cross-linked duplex, the two extinction coefficients were summed with the effect 
of the cross-linker ignored.  The unmodified intact duplexes did not survive the 
separation conditions and thus were not observed. 
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6.3.2.5 UV/vis thermal denaturation curves   
 DNA melting studies were performed on a Varian Cary Bio 100 UV/vis 
spectrophotometer (Palo Alto, CA) outfitted with a Peltier temperature control system.  
The concentration of the duplex was 5μM in 100 mM sodium acetate (pH 6).  The 
duplexes were heated at 1oC/min over a temperature range of 15-80oC.  The melting point 
was determined by finding the maximum of the first derivative curve.  
6.4 RESULTS AND DISCUSSION 
 Both LC-MS and LC-UV methods were used to characterize the reactions 
between RH1 or PhRH1 and oligodeoxynucleotide duplexes. .  The relative abundances 
of the cross-linked duplexes were compared for different duplexes upon reaction with 
RH1 and PhRH1, and the fragmentation patterns of the cross-linked duplexes revealed 
the positions of cross-link formation.   
6.4.1 LC-MS detection of cross-links 
 RH1 was incubated with each selected duplex and reacted under the conditions 
specified in the experimental section to form the reduced hydroquinone and to encourage 
the formation of interstrand cross-links.  Cross-links were formed between RH1 and five 
of the duplexes including DS1, DS2, DS3, DS4, and DS5, but not with DS6, DS7, and 
DS8, as described later.  For the five positive cases, the species detected by LC-MS 
included the unmodified single strands, the cross-linked duplexes, and low abundances of 
single strand monoadducts.  Examples of mass spectra arising from the LC-MS 
experiments are shown in Figure 2 and display the multi-charged molecular ion 
signatures of the single strands, the monoadducts, and the cross-linked duplexes.  Intact 
unmodified (i.e. non-cross-linked) duplexes were not detected.  While G/C rich duplexes 
may remain intact during HPLC separation and ESI-MS analysis, the organic solvent 
component of the mobile phase disrupts the weaker hydrogen bonding interactions of A/T 
rich duplexes, thus preventing their survival and detection.  In general, the cross-linked 
duplexes were typically detected in the 5- and 6- charge states.   






























































































































Figure 6.2 Selected mass spectra from LC-MS experiments for RH1 (a-d) and PhRH1 
(e-h) after reaction with DS4.  Elution times were as follows: a.  19.66-
20.4min., b .28.54-29.76 min, c. 33.57-34.43, d. 16.73-17.49 min., e. 19.17-
19.73 min., f. 28.88-30.53 min., g. 40.54-41.55, and h. 15.84-16.33 min.  
RH1 monoadducts are noted by $ and cross-links are noted by ◊ and PhRH1 
monoadducts are noted by & and cross-links by #. 
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Under similar reaction conditions, PhRH1 formed cross-links with the same duplexes as 
formed with RH1.  The PhRH1-cross-linked duplexes tended to elute slightly later than 
the RH1-cross-linked duplexes.  Monoadducted single strands were not observed in high 
abundances for either RH1 or PhRH1.  With many cross-linkers, monoadducts are more 
abundant than cross-links; however, the reaction mechanism of RH1 and other 
aziridinylbenzoquinones enhances cross-link formation.  After the first aziridine group 
has opened and has alkylated N7 on the guanine base, an electron pair is donated to the 
aromatic ring system which increases the reactivity of the remaining aziridine ring 
improving the yield of the cross-link over the monoadduct.36   
 To compare the reaction efficiencies of RH1 and PhRH1, the relative percentages 
of cross-linked duplexes were calculated as described above in Equation 1 (Figure 3).  
Cross-linking of the duplexes by RH1 appeared to be sensitive to the overall sequence of 
the duplex.  The relative cross-linking efficiencies of RH1 with DS1, DS3, and DS4 were 
all similar (approximately 4%).  DS1 and DS4 both have target sequences of 5’-dGNC 
while DS3 has a target sequence of 5’-dGAAC/5’-dGTTC.  DS4 has two cross-linking 
sites each with 5’-dGAC/5’-dGTC sequences.  At first glance, a comparison of the cross-
linking yields for DS2, with one 5’-dGAC/5’-dGTC target site, and DS4, with two 5’-
dGAC/5’-dGTC target sites, would appear to indicate a linear increase in cross-linking 
with the number of target sequences. However, MS/MS characterization of the cross-
linked DS4, as discussed below, indicates that only one of the two target sites actually 
undergoes cross-linking.  This would suggest that the increase in cross-linking efficiency 

































Figure 6.3 Relative percentages of cross-link formation for RH1 and PhRH1.   
the change in duplex conformation and stability that occurs when G/C rich sequences are 
located at the termini of oligodeoxynucleotides.  These differences were further explored 
by determining the melting temperatures of the five duplexes which are discussed in 
more detail below.  The cross-linking efficiency of DS5 was significantly greater than 
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observed for the other four duplexes.  This duplex contains two target sites with 5’-
dGAC/5’-dGTC and 5’-dGAAC/5’-dGTTC sequences.  The increase in cross-linking, in 
combination with dissociation results discussed below, indicates that cross-linking may 
occurr at either target site which therefore increases the probability of cross-linking.    
 For reactions of PhRH1, the lowest cross-linking efficiency was observed for 
DS1, indicating that this target site is the least accessible for reaction with the bulky 
phenyl derivative.  Cross-linking of DS2, DS3, and DS4 were generally similar, 
suggesting that the longer target sequence of DS3 did not provide an increase in 
flexibility that might enhance PhRH1 cross-linking.  As with RH1, the cross-linking of 
DS5 increased significantly over that of the other four duplexes, and cross-links at both 
target sites were confirmed by tandem MS.   
 The cross-linking efficiencies of PhRH1 were lower than RH1 for all five 
duplexes.  The difference in cross-linking efficiency was especially notable for DS1, 
suggesting that the target site of DS1 is fairly specific for the smaller RH1 and intolerant 
of the bulkier PhRH1.  The difference in cross-linking efficiencies was also significnat 
for DS3, DS4, and DS5, but the difference was diminished for reactions of RH1 and 
PhRH1 with DS2.  The similarity in cross-linking for DS2 might reflect greater flexibility 
in the target site which would permit PhRH1 cross-linking to a similar extent as RH1.  
These results are probed further by examining the melting temperatures of the five 
duplexes.   
 To further investigate the underlying reasons for variations in cross-linking by 
RH1 as a function of the DNA sequences, melting temperatures were measured for the 
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first five duplexes in Table 1.  The melting points spanned the range of 36.1 to 47.9 oC 
(Table 2), and the order of melting temperatures was DS2 < DS1 < DS3 < DS5 < DS4.   
Table 6.2 Melting temperatures of DS1-DS5  
Double Strand  Melting Temperature (oC)a  
DS1 38.2 ± 0.2  
DS2  36.1 ± 0.4  
DS3  41.6 ± 0.3  
DS4  47.9 ± 0.3  
DS5  44.1 ± 0.4  
 
The sequences with A/T rich terminal sequences, DS1, DS2, and DS3, all have lower 
melting temperatures than the sequences with G/C bases near the ends which is consistent 
with the well-known impact of the weaker hydrogen-bonding interactions of A/T versus 
G/C base pairs.  DS2 is the least thermally stable duplex and had the lowest cross-linking 
efficiency by RH1.  In addition, the cross-linking efficiencies obtained for DS2 with 
PhRH1 or RH1 were very similar- a result not observed for the other duplexes.  It is 
possible that the helix has destabilized and partially distorted, thus preventing RH1 from 
forming a stable interstrand cross-link.  The higher melting temperatures of the other 
sequences suggest greater stability which would better allow the duplex to remain in a 
conformation more suitable for cross-linking.  DS4 and DS5, which contain the same 
target sequence as DS2, had melting temperatures approximately 12 and 8oC higher than 
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DS2, respectively.  The additional stability of these two duplexes would allow the duplex 
to remain in a helical structure conducive to cross-linking efficiency which explains the 
increased difference in cross-linking between RH1 and PhRH1 in comparison to DS2.   
 In addition to the duplexes described above, the reactions of RH1 with three other 
duplexes resulted in no cross-linking although monoadducts were observed with the 
individual single strands of both DS6 and DS7 which contain guanine residues.  The lack 
of cross-linking to either DS6, a self-complementary 12-mer with a 5’-dCG binding site, 
or DS7, a 14-mer with a 5’-dGC binding site, suggests that a minimum distance between 
guanine bases is required to facilitate cross-linking.  With the 5’-dCG or 5’-dGC 
sequences, the guanine bases are on adjacent base pairs- a distance too constricted for 
optimal bridging by the RH1 ligand.  Fragmentation of the monoadducted single strands 
resulted in loss of the modified guanines suggesting covalent modification.  DS8 was 
chosen to determine if reactions with adenine or thymine were possible in the absence of 
guanine.  No monoadduction or cross-linking was observed for this duplex.   
6.4.2 Fragmentation Patterns of Cross-linked Duplexes   
 The sites of the cross-linking reactions were probed based on the fragmentation 
patterns generated upon CID or IRMPD of the cross-linked DNA/RH1 ions. Examples of 
the resulting CID and IRMPD mass spectra are shown in Figure 4 for (DS3 + RH1)6-, and 
similar patterns were observed for all the cross-linked duplexes (in the 6- charge state).  
CID spectra of the cross-linked duplexes in the 6- charge state generally resulted in 
fragmentation occurring at the site of cross-linking.  For instance, cleavage of the N- 





















































Figure 6.4 CID (a) vs. IRMPD (b) spectra for [DS3+RH1]6-.  Ssa and ssb refer to the 
single strands as described in Table 1.  The irradiation time for IRMPD was 
5 ms.  Fragments from ssa are in bold italics.   
glycosidic bond between the guanine and deoxyribose sugar resulted in the formation of 
complementary ions: single strand ions with one guanine lost and single strand ions 
containing both the cross-linker and an extra guanine (the one lost from the companion 
strand).  A summary of the general fragmentation pathways of the cross-linked duplexes 
is shown in Scheme 2.  The retention of the cross-linker and one guanine from the 
opposite strand confirms that cross-linking is occurring between the two strands.  While 
these complementary fragment ions are helpful for confirming that interstrand cross-


















Scheme 6.2 Cartoon of fragmentation process of a duplex with an interstrand cross-link 
at two guanine bases after IR irradiation.   
fragmentation occurs as well, resulting in the production of a - B and w ions.  In the 
example shown in Figure 4, w8 ions were produced from each strand.  This indicates 
backbone fragmentation 3’ to guanine bases in this duplex, but again does not 
conclusively identify the site of cross-linking because the complementary a - B ions are 
not present in the spectrum.  The 5- charge states of the cross-linked duplexes were also 
examined by CID.  As has been seen with duplexes in low charge states in the past,67 the 
major dissociation pathway was loss of unmodified bases.  Backbone fragmentation, 
similar to what was observed upon dissociation of the 6- charge state, was also observed. 
As an alternative to conventional CID, IRMPD was also used to characterize the 
cross-linked duplexes.  In IRMPD, ions are energized by absorption of IR photons rather 
than by a collisional process, typically affording very efficient dissociation with the 
extent of fragmentation dependent on the irradiation time.  For very low irradiation times, 
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the most abundant product occurred due to the loss of water.  Using slightly longer 
irradiation times (3 ms), CID-like spectra were produced. The dominant fragmentation 
process involved separation of the strands via cleavage adjacent to a cross-linked guanine 
site, resulting in formation of complementary single strands, either with a guanine loss or 
with retention of the RH1 cross-linker plus an extra guanine from the other strand (see 
Scheme 2).  Low abundances of backbone fragment ions, such as w82- ions from both 
strands, were also observed.  Increasing the irradiation time to 5 ms promoted secondary 
dissociation of the single strand species described above, yielding backbone fragment 
ions as shown in Figure 4.  For example, both the pair of w82- ions and the complementary 
a6 - G ions are observed, in this case confirming the site of cross-linking at those guanines 
as illustrated in Scheme 2.   
 CID and IRMPD spectra were also obtained for the cross-linked DS1 and DS2 
products (spectra not shown).  As with DS3, fragmentation was observed at the site of 
cross-linking with the primary cleavage occuring at the N-glycosidic bond between the 
modified guanine and the sugar.  Backbone fragments indicating fragmentation 3’ to the 
cross-linked nucleosides were observed for both cross-linked duplexes.   
 IRMPD was especially useful for characterizing the cross-linked DS4 duplex 
(Figure 5a).  There are two potential cross-linking sites, and it was unclear whether a 
terminal target sequence would have the correct secondary structure to permit cross-
linking.  The IRMPD mass spectrum of the RH1 cross-linked duplex in the 6- charge 
state after 5 ms of irradiation time shows the (a4 - G)- ion from ssb as the most abundant 
fragment.  The corresponding w102- ion is also observed.  Fragments from the other strand  























































Figure 6.5 .  IRMPD spectra for selected cross-linked duplexes.  Dissociation spectrum 
from [DS4+RH1]6- after 5 ms irradiation time (a) and dissociation spectrum 
from [DS5+RH1]6- after 3 ms irradiation time (b).  Fragments from ssa are 
in bold italics and the diamond indicates the presence of the cross-linker. 
include the (a9 – G)2- ion as well as the complementary w5- ion.  The significant 
abundance of these fragment ions, as well as the presence of both sets of complementary 
fragment ions indicates that the majority of the cross-linking occurred at the internal 
target sequence.  There is a low abundance fragment ion corresponding to the w2- 
fragment from strand b.  This could indicate cross-linking at the terminal guanine, but 
there are no complementary fragment ions observed such as the (a12-G)2- - a fragment ion 
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which would be within the m/z range of the instrument.  This suggests that the 
fragmentation at that base is not related to cross-linking.   
 As with DS4, there were two possible sites of cross-linking for duplex DS5: a 5’-
dGAC/5’-dGTC sequence and a 5’-dGAAC/5’-dGTTC sequence.  A duplex with two 
different binding sites that vary in the distance between the guanines was chosen to 
determine if a cross-linking preference would be seen between the two target sequences.  
As shown in Figure 5b, the IRMPD spectrum acquired after 3 ms irradiation displays the 
single strand-type fragment ions described earlier (both single strands with guanine loss 
and single strands with the additions of the cross-linker and the guanine from the opposite 
strand).  This indicates that cross-links are present but does not indicate to which guanine 
the cross-linkers were attached.  Backbone fragments from strand a present in the 
dissociation spectrum consist of the a3 - G and w112- ions and the (a9 – G)2- and w5- ions.  
Strand b fragment ions are a3 - G and w112- ions and the (a10 - G)2-, (a10 – G)3- and w4- ions.  
These sets of complementary fragment ions correspond to fragmentation at both possible 
cross-linking sites, indicating that both cross-linking sites are active.  In addition to the 
complementary fragments, two backbone fragments containing the cross-link were 
observed, including w11 ions from each strand with each retaining the cross-linker RH1 
and an extra guanine.  The w11 ion usually does not retain the neighboring base (from the 
same strand) after fragmentation, but the ions are relatively minor overall.  The addition 
of the cross-linked guanines to the w11 ions indicate that, for these particular ions, the 
cross-link occurred at the 5’ guanine on each strand.  The presence of this ion from each 
strand is a further indication that both sites, the 5’-GNC and the 5’-GNNC sites, 
participate in interstrand cross-linking.   
 To map the fragmentation trends and genealogies in more detail, time-variable 
IRMPD experiments were undertaken.  For this strategy, the irradiation time is varied to 
alter the total energy deposition as well as the secondary activation of primary product 
ions.   The resulting graph obtained for [DS4 + RH1]6- ion is shown in Figure 6.  The 





































Figure 6.6 Time-variable IRMPD of  [DS4+RH1]6- 
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time is increased, the proportion of informative backbone fragments increases.  Even 
longer irradiation times result in both an increase in backbone fragmentation at the site of 
cross-linking and additional backbone fragments remote from the cross-linking sites with 
the latter remaining relatively minor.  The graph in Figure 6 indicates that the first 
dissociation event is cleavage between the cross-linked guanine and the sugar, leading to 
strand separation.  These primary product ions then dissociate further to produce 
backbone fragments at the cross-linked nucleobase.  These major backbone 
fragmentation patterns are summarized in Figure 7 for all five duplexes.  Further 
irradiation leads to high energy fragments along the backbone away from the cross-linked 
guanines to form.  Not only can IRMPD be used to identify cross-links and where they 
occur, but it can also be used to determine fragmentation pathways. 
6.5 CONCLUSIONS 
 RH1 was found to form cross-links between oligonucleotide duplexes with 
several target binding sequences.  In addition to two 5-dGNC sequences, RH1 formed 
cross-links at a binding site with a 5’-dGAAC sequence indicating that the cross-link is 
capable of extending an additional distance.  However, a duplex containing a 5’-GC 
sequence did not have cross-links formed after the reaction suggesting that a minimum 
distance between the guanine bases is necessary for cross-links to form.  A terminal 
binding site did not produce cross-links indicating that a local helical structure was 
necessary for cross-linking.  The addition of the phenyl group did lower cross-linking 






































was similar between the two ligands suggesting that the binding site on this strand may 
have been more open than in the other duplexes.  For the cross-linked duplexes, IRMPD 
provided useful information to determine where the cross-links occurred.  The tunability 
of IRMPD, based on the irradiation times chosen, was used both to confirm the ligands 
were cross-linking and to determine how backbone fragments were forming.  Further 
studies with various derivatives of RH1 will provide a greater understanding of the 
interaction between the aziridinylbenzoquinone cross-linkers and the target binding 
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Chapter 7: Examination of the Effect of the Annealing Cation on 
Higher Order Structures Containing Guanine or Isoguanine Repeats 
7.1 OVERVIEW 
 Isoguanine (2-oxo-6-amino-guanine), a natural but non-standard base, exhibits 
unique self-association properties compared to its isomer, guanine, and results in 
formation of different higher order DNA structures.  In this work, the higher order 
structures formed by oligonucleotides containing guanine repeats or isoguanine repeats 
after annealing in solutions containing various cations are evaluated by electrospray 
ionization mass spectrometry (ESI-MS) and circular dichroism (CD) spectroscopy.  The 
guanine-containing strand (G9) consistently formed quadruplexes upon annealing, 
whereas the isoguanine strand (Ig9) formed both pentaplexes and quadruplexes 
depending on the annealing cation.  Quadruplex formation with G9 showed some 
dependence on the identity of the cation present during annealing with high relative 
quadruplex formation detected with six of ten cations.  Analogous annealing experiments 
with Ig9 resulted in complex formation with all ten cations, and the majority of the 
resulting complexes were pentaplexes.  CD results indicated most of the original 
complexes survived the desalting process necessary for ESI-MS analysis.  In addition, 
several complexes, especially the pentaplexes, were found to be capable of cation 
exchange with ammonium ions. Ab initio calculations were conducted for isoguanine 
tetrads and pentads coordinated with all ten cations to predict the most energetically 
stable structures of the complexes in the gas phase.  The observed preference of forming 
quadruplexes versus pentaplexes as a function of the coordinated cation can be 
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interpreted by the calculated reaction energies of both the tetrads and pentads in 
combination with the distortion energies of tetrads. 
7.2 INTRODUCTION 
 The assembly of guanine base repeats in tetrads around central cations results in 
the formation of higher order DNA structures known as quadruplexes.1  Quadruplexes 
have been studied extensively due to their role in halting both the immortalization of cells 
and tumor growth by preventing the binding of telomerase, a key enzyme responsible for 
the elongation of DNA.2-5  Bases other than guanine are also capable of forming higher 
order DNA structures including triplexes, quadruplexes, and pentaplexes.6  In addition to 
the growing body of evidence that supports the presence and function of higher order 
DNA structures formed by natural DNA bases, there is increasing interest in designing 
and exploiting the ability of both modified bases and non-standard bases to engage in 
intermolecular interactions, creating novel architectures for sensing applications and 
possible use as ion channels.7-9  
 Isoguanine, a non-standard but naturally occurring base, has been shown to form 
higher order complexes similar to guanine (Scheme 7.1).8, 10-15  While the difference 
between guanine and isoguanine only involves the transposition of the carbonyl and 
amino groups, the change in the structure of isoguanine has been shown to favor the 
formation of pentameric rather than tetrameric multimers in studies of the interactions of 












































































































Scheme 7.1  a. Structures of deoxyguanosine and deoxyisoguanosine.  b. Typical 
structures of guanine tetrad and isoguanine pentad around a central cation, 
M+.  R refers to the sugar or sugar phosphate backbone.  
rationalized based on the decrease in the hydrogen bonding angle between bases which 
favors inclusion of a fifth base in the ring to maintain planarity.  In addition, several  
computational studies have reported that isoguanine pentads formed around various 
monovalent cations have high interaction energies between bases and are planar 
complexes while the tetrads are far less planar.18-21  Previous studies have noted a strong 
preference for the self-assembly of isoguanine around cesium over potassium ions.22  In 
addition, individual isoguanosine units functioning as ionophores were found to be 
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selective for singly charged cations in the order Cs+ >> Rb+ > K+ > Na+ and for doubly 
charged cations in the order Ca2+ > Sr2+ > Ba2+ > Mg2+.15  The cation in the central cavity 
also has a significant template role in the formation of multimeric DNA structures from 
guanine- and isoguanine-containing strands.  Both monovalent and divalent cations can 
support the formation of quadruplexes from guanine-rich strands.23-27  In contrast, 
isoguanine-containing strands form pentaplexes around cesium cations but form 
quadruplexes around potassium, whereas the analogous guanine-containing strands 
consistently form quadruplexes.28  The impact of the central cation on the formation and 
stability of pentaplexes by isoguanine-containing strands has not been systematically 
explored.    
 ESI-MS has been increasingly employed as a versatile and sensitive tool for the 
study of higher order DNA complexes.29, 30  While most of the studies have focused on 
quadruplexes31-36 and their interactions with drugs or small molecules,37-44 DNA triplexes 
have also been characterized.45   ESI-MS allows ready assessment of the stoichiometries 
of complexes containing different numbers of cations and differentiation of single strand 
and multimeric species. Circular dichroism (CD) is also an established technique for 
studying biomolecular structures, including guanine quadruplexes in which the stacking 
of guanine bases affords strong optical activity.42, 46-50  While CD is rather unresponsive 
to changes in fine structure or the sequences of the strands involved in the quadruplexes, 
it is sensitive to the overall conformations of the quadruplexes.51  In addition, most salts 
and buffers are compatible within the range of wavelengths of interest for studying DNA 
complexes.  Polyisoguanine strands have also been studied previously by CD 
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spectroscopy52 as have complexes composed of individual bases around a central 
cation.15  
 Unlike guanine quadruplexes and other non-Watson-Crick interactions53, 
isoguanine quadruplexes and pentaplexes have not been studied experimentally in detail.  
However, high level ab initio calculations provide an alternative approach to predict the 
structures of higher order DNA complexes.  While the study of full quadruplex or 
pentaplex complexes is extremely resource-intensive due to the large number of atoms 
involved in the calculations, high level ab initio calculations have been carried out on 
smaller-scale isoguanine tetrads and pentads.18-22  Most investigations completed 
previously focused on alkali metal ions alone and did not explore a full range of metals 
cations. 
 In this work, the formation of quadruplexes and/or pentaplexes by strands 
containing either guanine repeats or isoguanine repeats is studied by ESI-MS and CD 
spectroscopy.  The strands are annealed in solutions containing a variety of singly 
charged and doubly charged template cations including Li+, Na+, K+, Rb+, Cs+, NH4+, 
Mg2+, Ca2+, Sr2+, and Ba2+.  The wide range in ionic radii of these cations allows 
investigation of the effects of charge and ion size on the formation of higher order 
complexes.  ESI-MS is used to determine the extent of complex formation as well as the 
identity and number of the central cations incorporated in the complexes.  CD 
spectroscopy provides information about the structures and conformations of the 
complexes and is used to reveal how sample preparation affected the structures of 
interest.  Ab initio optimizations with density functional theory are undertaken for 
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isoguanine tetrad and pentad structures incorporating all ten cations. For each complex, 
three different symmetries, specifically C4h, D4 and S8 for isoguanine tetrads and C5h, D5 
and S10 for isoguanine pentads, are investigated.  The computational results are used to 
support the experimentally observed trends concerning the formation of quadruplexes and 
pentaplexes by isoguanine-containing strands. 
7.3 EXPERIMENTAL 
7.3.1 Materials.   
 The isoguanine-containing strand studied here, dTIgIgIgIgTTTT (Ig9), where Ig 
refers to isoguanine, was synthesized as described previously.7   The corresponding 
guanine-containing strand, dTGGGGTTTT (G9), was obtained from IDT DNA, Inc 
(Coralville, IA).  Spectroanalyzed methanol, HPLC grade water, and ammonium acetate 
were purchased from Thermo Fisher Scientific (Waltham, MA).  Lithium chloride, 
rubidium chloride, cesium chloride, magnesium chloride dihydrate, calcium chloride 
dehydrate, strontium chloride hexahydrate, and barium chloride were purchased from 
Sigma Aldrich (St. Louis, MO).  Sodium chloride and potassium chloride were obtained 
from EM Science (Gibbstown, NJ).  All salts were dissolved in water to make stock 
solutions.  Ionic radii are based on Goldschmidt hard sphere ionic radii.54 
7.3.2 Methods.   
 Both G9 and Ig9 were annealed in a similar manner.  The strands (100-125 μM 
single strand) and appropriate salts at concentrations described in the text were placed in 
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a hot water bath and cooled to room temperature overnight (approximately 12 hours).  
The annealed solutions were placed in the freezer until analyzed.  Immediately before 
ESI-MS analysis, all solutions except those containing ammonium acetate were desalted 
using Millipore (Billerica, MA) Biomax Ultrafree 5 kDa molecular weight centrifugal 
filters.  After desalting, ammonium acetate and methanol were added to the solutions to 
assist desalting and enhance desolvation of the analytes.  The ammonium acetate (50 mM 
final concentration) and methanol (20% by volume) were added no more than two 
minutes before analysis.  Assuming complete formation of the quadruplexes, in the case 
of G9, or pentaplexes, in the case of Ig9, the final concentrations of the complexes were 
approximately 3 μM.  ESI-MS analysis was performed on a Thermo LTQ mass 
spectrometer (San Jose, CA).   Analysis was performed in the negative mode with a 
heated capillary temperature of 90oC and a spray voltage of 3.5 kV.  The tube lens 
voltage was approximately -250 V.  
 To estimate the relative complex formation of quadruplexes or pentaplexes from 
the ESI mass spectra, peak areas of the complexes were summed and divided by the peak 
areas of the complexes and the free single strands as shown in the following equation: 
Relative Complex Formation       (7.1) 
where PAQ and PAP refer to the peak areas of the quadruplex and pentaplex species, 
respectively, and PASS refers to the peak area of the single strand.   There were no 
pentaplexes detected for the G9 solutions, resulting in PAP = 0 for all G9 solutions.  
Results discussed in this work are the average of three analyses.   
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 Annealed solutions of G9 and Ig9 were also analyzed by CD spectroscopy via a 
Jasco (Easton, MD) J-815 circular dichroism instrument.  The solutions were analyzed in 
a 0.1 cm cuvette over a wavelength range of 320 to 220 nm.  Three sets of spectra were 
collected for each mixture: the first after simple dilution in water to 300 μl, the second 
after filtration with the 5kDa molecular weight filters as described above, and the third 
after adding ammonium acetate to the filtered solution so that the final concentration of 
ammonium acetate in the solution was 50 mM.   Five scans were averaged for each 
spectrum.  For the solutions analyzed before desalting, individual blanks containing the 
salt used for annealing were subtracted through the software.  A water blank and a 50 
mM ammonium acetate blank were subtracted from the spectra taken after desalting and 
the spectra taken after addition of ammonium acetate, respectively.  CD spectra were not 
normalized against one another. 
 For each complex, three conformations representing three molecular point groups 
were constructed for ab initio optimizations using B3LYP/lacv3p**.55  This basis set, 
which utilizes effective core potentials for K+, Rb+, Cs+, Ca2+, Sr2+, and Ba2+, and 6-
311G** for the other cations, offers a reasonable balance between efficiency and 
accuracy in studying complexes containing metallic elements. The molecular symmetry 
was enforced during the optimization. All the calculations were performed using the 
Jaguar module (version 7.5) of Schrodinger, LLC.  Considering that the formation of 
isoguanine quadruplexes requires the tetrad planes be parallel to each other, a constrained 
optimization that enforces the planarity of tetrad was employed for each of the tetrads. 
Technically, the cation was placed in the origin and the tetrad planes were perpendicular 
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to the Z axis. The constraint was imposed by making the Z-coordinates z for the four 
isoguanines above the XY plane and -z for the four isoguanines below the XY plane, 
where z is an optimized parameter.  Similar conditions were used for the isoguanine 
pentad calculations.  It should be noted that neither a frequency analysis nor BSSE (basis 
set superposition error) calculation was performed since the major purpose was to study 
the geometries of the complexes and to compare the relative template ability of the ten 
cations to promote the formation of isoguanine tetrads and pentads. According to recent 
literature, the zero point and BSSE corrections should not change the overall trends.18, 20 
7.4 RESULTS AND DISCUSSION 
7.4.1 ESI-MS analysis of G9.   
 G9 was annealed in the presence of ten different cations, and the resulting 
solutions were analyzed by ESI-MS after removal of excess salts.  Representative spectra 
from these solutions are shown in Figure 7.1.  The spectra obtained for G9 with Li+, 
Mg2+, Na+, and Cs+ show little or no presence of quadruplexes, either due to lack of 
formation during annealing or due to dissociation of the quadruplexes during clean-up (as 
discussed more later).  In contrast, the spectra obtained for G9 with Sr2+, K+, NH4+, Ba2+, 
Rb+ displayed large abundances of quadruplexes. G9 annealed in Ca2+ resulted in 
approximately equal abundances of single strands and quadruplexes.  The results are 
summarized in bar graph form in Figure 7.2 in the order of increasing ionic radius of the 
annealing cation.  It is clear that the cations within a certain range of radii afford far more 
efficient quadruplex formation as opposed to cations with very large (Cs+) or small (Li+) 
radii.  
 
 Figure 7.1 ESI-mass spectra of G9 after annealing in a 440mM solution of the salt 
noted in the spectra.  Q refers to the quadruplex while ss denotes the single 
strand. 
 In addition to allowing the ready assessment of the efficiency of quadruplex 
formation, ESI-MS allows the determination of the identity and number of central cations 
present within the structures, as summarized for ions in the dominant 6- charge states in 
Table 7.1.   For most of the solutions, the ESI mass spectra revealed that the number of 
central cations in the dominant form of the quadruplex was three, along with far less 
abundant complexes containing varying numbers of cations.  This is consistent with a 
pattern reported previously in which n - 1 central cations are associated with n number of 
tetrads in a tetramolecular quadruplex.56  Based on the G9 sequences used in the present 
 132 
 133 
study, the formation of four tetrads is possible, supporting the inclusion of three cations.  
Overall, the number of cations included generally followed the n - 1 rule for singly  
Table 7.1 Table comparing the identity and number of cations found associated with 
the 6- charge state of the G9 intermolecular quadruplex.  Asterisks denote 
those quadruplexes in which the annealing cations are replaced by 
ammonium ion.   
Most abundant Q6- ion 
Cation m/z # cations 
Li+ 1857 3* 
Mg2+ 1864 4 
Na+ 1861 3 
Ca2+ 1857 3* 
Sr2+ 1877 2 
K+ 1867 3 
NH4+ 1857 3 
Ba2+ 1894 2 
Rb+ 1857 3* 
Cs+ 1857 3* 
 
charged cations. However, for the divalent cations Sr2+ and Ba2+, only two cations were 
associated with the quadruplexes.  While these cations are large, several monovalent 
cations that were larger or the same size promoted the incorporation of three cations.  
Thus, it appears that the greater charge density of Sr2+ and Ba2+ prevents the inclusion of 
a third cation in the quadruplex.  In contrast to the results for the solutions containing Sr2+ 
and Ba2+, four Mg2+ ions were incorporated in the quadruplexes.  This ion, with a radius 
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approximately half that of Ba2+, is the smallest one retained within the complex.  It 
appears that quadruplex formation and cation retention are related to both the size and 
charge of the annealing cations.   
 In several cases, the m/z values of the quadruplexes in the mass spectra indicate 
that the central cations are not the original templating cations used during annealing but 
instead are ammonium ions.  Quadruplexes in which the cations were replaced by 
ammonium are denoted by a box in Figure 7.2.  Ammonium acetate is added to each 
solution after the desalting procedure that is essential for successful ESI-MS analysis of 
solutions containing high concentrations of non-volatile salts.  Cation exchange within G-
quadruplexes has been observed previously by Ma et al. and attributed to the sequential 
replacement of cations of lower affinity with those of higher affinity.31  The quadruplexes 
that undergo exchange of the annealing cations for NH4+ include those originally 
annealed in the presence of Li+, Ca2+, Rb+, and Cs+.  In fact, the Li+ and Cs+ solutions 
produced very low abundance quadruplexes, possibly indicative that these quadruplexes 
were only formed after the addition of ammonium acetate and never actually incorporated 
the very small Li+ or very large Cs+ ions (supported by CD results discussed below).  
However, both the Ca2+ and Rb+ solutions exhibited high abundances of quadruplexes, 
indicating the ability to facilitate quadruplex formation despite the subsequent exchange  
with ammonium.  Rb+ is the only cation that was larger than ammonium in terms of ionic  
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Figure 7.2 Chart of relative quadruplex formation for G9 annealed in 440 mM salt as 
determined from the ESI-mass spectra.  Boxes around the cations indicate 
that the ESI-mass spectra showed replacement of the annealing cations with 




radius yet was still able to promote quadruplex formation.  The larger size of Rb+ and 
rather different electrostatic interactions may have contributed to its ready exchange for 
NH4+ prior to ESI-MS analysis.  The formation of quadruplexes in the presence of Ca2+ 
and then subsequent exchange of Ca2+ for NH4+ is interesting as Ca2+ is the only divalent 
cation to exchange with NH4+.  The other two doubly charged cations, Sr2+ and Ba2+, for 
which quadruplexes were very abundant, were larger than Ca2+.  It is possible that the 
size and charge density of Ca2+ was suitable for facilitating the initial quadruplex 
assembly but ultimately the greater NH4+ affinity caused cation exchange during the 
desalting and ammonium acetate dilution required for ESI-MS analysis.  In general, the 
exchange of template cations for ammonium seen here is consistent with previous results 
reported by Ma et al.31   
7.4.2 ESI-MS of Ig9.   
 As with G9, the annealed Ig9 solutions were analyzed by ESI-MS after desalting.  
Representative spectra are shown in Figure 7.3.  The Ig9 solutions showed large relative 
abundances of higher order complexes versus the single strands for all cations regardless 
of size or charge.  In addition, the majority of the solutions resulted in almost entirely 
pentaplex formation with minimal quadruplex formation except for the Ig9 annealed in 
K+ and NH4+ solutions.   Even the smallest singly charged cation, Li+, promoted almost 
exclusive pentaplex formation.  Ig9 annealed in the NH4+ solution resulted in 
approximately equal abundances of quadruplexes and pentaplexes.  As summarized in 
Figure 7.4, the change in the relative abundances of quadruplexes and pentaplexes 
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between solutions containing different annealing cations is striking, even for those 
cations with similar ionic radii.  For example, Sr2+, with an ionic radius of 1.27 Å, 
stabilizes the formation of the pentaplex, whereas K+, with an ionic radius of 1.33 Å, 
preferentially stabilizes the quadruplex.  In this case, the increased charge density of Sr2+ 
likely plays a role in pre-organizing the wider central cavity of the pentaplex as opposed 
to the quadruplex.  A similar situation is seen for the NH4+ and Rb+ solutions in which the 
ionic radii, 1.43 Å for NH4+ and 1.49 Å for Rb+, are very similar, whereas the 
distributions of quadruplexes and pentaplexes present are quite different.  Rb+ promoted 
only pentaplex formation yet annealing in NH4+ yielded both quadruplexes and 
pentaplexes.  There appears to be a narrow range of acceptable ion sizes capable of 
supporting the formation of quadruplexes for Ig9 that is only met by K+ and, to a lesser 
extent, NH4+.  In contrast, the pentaplexes are formed in the presence of cations of a 
broad range of sizes and charge densities. 
 The mass spectra of the Ig9 solutions were also examined to determine the 
number and identity of the included central cations.  In most of the pentaplex complexes, 
the central cations appeared to have been replaced by ammonium cations. This was true 
for Li+, Mg2+, Na+, Ca2+, and Rb+.  Also, the pentaplexes contained three central cations 
which is consistent with the (n - 1) rule seen for guanine-based quadruplexes.  Only the 
pentaplexes formed around the large doubly charged cations, Sr2+and Ba2+, retained these 
cations.  The pentaplexes annealed in Cs+ retained two cesium cations with one additional 
NH4+ cation.  Given the apparent preference for three cations in the central cavity, it 
appears that one NH4+ cation replaced one Cs+ cation during the de-salting and  
 
Figure 7.3 ESI-mass spectra of Ig9 after annealing in a 440 mM solution of the salt 
noted in the spectra.  Q refers to the quadruplex and P refers to the 
pentaplex.. 
ammonium acetate dilution procedure.  The Ig9 annealed in a K+ solution resulted in both 
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Figure 7.4 Chart of relative complex formation for Ig9 annealed in 440 mM salt as 
determined from the ESI-MS.  The values represent the average of three 
samples.  Boxes around the cations indicate that the ESI-mass spectra 
showed replacement of the annealing cations with ammonium.  Only one of 
three Cs+ cations was exchanged. 
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7.4.3 ESI-MS of G9 and Ig9 annealed in low salt concentration solutions.   
 To determine the effects of salt concentration during annealing on complex 
formation, both G9 and Ig9 were annealed in solutions containing 10 mM or 150 mM 
salts.  After annealing, the resulting solutions were desalted in a similar fashion to 
solutions annealed in 440 mM salt, re-constituted in 50 mM ammonium acetate, and 
analyzed by ESI-MS.  The results obtained for the G9 solutions are summarized in Figure 
7.5a.  In several cases, there was virtually no change in the relative abundances of 
quadruplexes when compared to the ESI mass spectra obtained for the high salt 
concentration solutions discussed in Figure 7.2. G9 annealed in Sr2+, K+, NH4+, and Ba2+ 
retained high levels of quadruplexes, while Li+, Ca2+, and Cs+ showed similar low 
abundances of quadruplexes.  The two cases of greatest interest were the G9s annealed in 
Ca2+ and Rb+.  For these solutions, the decrease in salt concentration of the annealing 
solution resulted in a corresponding decrease in quadruplex formation, indicating that the 
stability of these quadruplexes is dependent on the salt concentration of the solution and 
suggesting that the quadruplexes are less robust.  In addition, the spectra of solutions of 
G9 annealed in Mg2+ were also different than the spectra obtained at high annealing 
concentrations.  The peaks corresponding to the quadruplexes incorporating Mg2+ were 
much broader than usually observed (spectra not shown), a feature that indicates the 
quadruplexes possess different numbers and identities of cations, thus yielding a range of 
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Figure7.5 Charts of relative complex formation under low ionic strength conditions for 
G9 quadruplexes (a) and Ig9 quadruplexes and pentaplexes (b).  G9 was 
annealed in 150 mM and 10 mM salts and Ig9 was annealed in 10 mM salts.  
The values represent the average of three samples.  Boxes around the cations 
indicate that the ESI mass spectra showed replacement of the annealing 
cations with ammonium.   
CD results discussed below indicate that Mg2+ is capable of templating quadruplex 
formation with G9 although the structures do not survive desalting.  While the overall 
quadruplex formation did not change significantly between 150 mM and 10 mM salt 
concentrations, these results do suggest a difference in stability. 
 The impact of the salt concentration on the formation of higher order complexes 
of Ig9 was evaluated more selectively due to the limited quantity of Ig9.  Ig9 was 
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annealed in 10 mM Na+, K+, NH4+, Ba2+, or Cs+, a subset of cations that includes a range 
of ionic radii.  The relative abundances of pentaplexes and quadruplexes under these 
conditions are summarized in Figure 7.5b.  Ig9 annealed in the presence of 10 mM Na+, 
Ba2+, or Cs+ resulted in similar distributions of complexes to those obtained for the 
solutions annealed at higher salt concentrations (seen in Figure 7.5).  However, there 
were notable differences for the 10 mM K+ and NH4+ solutions.  Unlike Ig9 annealed at 
high salt conditions, the solutions annealed in 10 mM K+ or NH4+ resulted in formation of 
mostly pentaplexes rather than quadruplexes that dominated at higher salt 
concentrations.   In addition, the isoguanine pentaplexes formed around potassium at low 
salt concentrations tended to exhibit loss of an isoguanine base.  It is unclear why the loss 
of isoguanine would occur solely under these conditions since it did not occur for other 
solutions annealed in the presence of 10 mM cations (i.e. low salt conditions) nor did the 
loss of isoguanine base occur for the solutions annealed in the presence of high 
concentrations of potassium.  The differences seen for the solutions containing potassium 
and ammonium suggest that the pentaplexes are more stable than the quadruplexes under 
low salt conditions, but that the quadruplex can be stabilized at higher salt concentrations.  
Because the solutions containing G9 or Ig9 retained different distributions of complexes 
depending on the nature of the salt, it is apparent that the desalting and ammonium 
acetate dilution procedure used for processing all the solutions did not cause systematic 
disassembly and re-organization of the complexes to one uniform species.   
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7.4.4 CD spectra of G9 and Ig9.   
 To further evaluate the structures of the quadruplexes and pentaplexes formed by 
G9 and Ig9, respectively, and to determine the impact of the desalting and ammonium 
acetate dilution procedures used for the ESI-MS analysis, the solutions described above 
were analyzed by CD spectroscopy before desalting (after annealing in 440 mM salt), 
after desalting, and after addition of ammonium acetate (to 50 mM).  Both the quadruplex 
structures and pentaplex structures formed by G9 and Ig9 are expected to provide good 
CD spectra as stacking between the bases, which is present in quadruplexes and 
pentaplexes, imparts optical activity to the structures.  Since the salts are not significantly 
optically active under circularly polarized light from 220 to 320 nm, the presence of these 
salts does not hinder analysis of the solutions.  Representative CD spectra are shown in 
Figures 7.6 and 7.7 for the G9 and Ig9 solutions, respectively, and all the results are 
summarized in Tables 7.2 and 7.3.   
The quadruplexes formed by G9 are parallel tetramolecular quadruplexes which 
have a positive band around 264 nm and a smaller negative band around 243 nm.  Table 
7.2 provides a summary of peak locations and intensities for all solutions.  Solutions of 
G9 annealed in the presence of Na+, Sr2+, K+, NH4+, Ba2+, and Rb+ produced strong 
positive bands at 264 nm before desalting.  The band intensities at 264 nm were moderate 
for the Mg2+ and Ca2+ solutions, and low for the Li+ and Cs+ solutions.  Examples of 
strong, moderate, and weak positive bands produced by solutions annealed in K+, Mg2+, 
and Cs+, respectively, are shown in Figure 7.6a and Figure 7.6b before and after 
desalting. 
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Table 7.2 Wavelength maxima of positive peaks and intensities at 264 nm from CD 
spectra from solutions of G9. 














Li+  257 257 258 Li+  0.61 0.29 0.47 
Mg2+  260 262 259 Mg2+  2.09 0.33 0.59 
Ca2+  261 264 260 Ca2+  2.66 0.60 0.80 
Na+  265 259 259 Na+  4.54 0.39 0.54 
Sr2+  263 263 263 Sr2+  3.49 2.21 1.88 
Ba2+  264 264 263 Ba2+  4.01 2.01 1.98 
K+  264 264 264 K+  4.88 3.22 2.97 
NH4+  263 -  264 NH4+  3.92 - 3.49 
Rb+  264 264 264 Rb+  4.69 2.64 1.90 
Cs+  256 256 260 Cs+  0.45 0.18 0.36 
 
When compared to the CD spectrum of a DNA solution at 95 oC, which is a sufficiently 
high temperature to convert all higher order structures to single strands, the CD spectra 
acquired for the solutions annealed in Li+ and Cs+ are similar in both spectral shape and 
intensity, indicating that Li+ and Cs+ do not favor higher order structure formation, which 
is in agreement with the ESI-MS results.   The loss of base stacking as the quadruplex 
converts to the single strand diminishes the optical activity and decreases the 
corresponding CD intensities, indicating a loss of secondary structure.  The majority of 
the CD spectral findings are consistent with the ESI-MS results for quadruplex formation 
discussed above in terms of the relative abundances of quadruplexes, with the exception 
of the results for Mg2+ and Na+.  Based on the mass spectral data, G9 annealed in the 
presence of Mg2+ and Na+ displayed low abundances of quadruplexes whereas the 
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Figure 7.6 CD spectra of G9 samples annealed in the presence of Mg2+, K+, and Cs+ 
before desalting (a) and after desalting (b).  Initial salt concentrations, after 
dilution to working volumes, was approximately 18 mM.  Assuming 
complete quadruplex formation, the concentration of quadruplex after 
dilution was approximately 3 μM.  CD spectra before desalting, after 
desalting, and after the addition of ammonium acetate for samples annealed 
in the presence of Sr2+ (c) and Na+ (d). 
 To investigate the stability and survival of the quadruplexes, as well as to probe 
the reasons for the differences in the relative abundances of Mg2+ and Na+ complexes 
obtained from the ESI-MS results versus the CD results, CD spectra were collected for 
the same solutions after desalting and after dilution in ammonium acetate, thus 
reproducing the conditions used for the ESI-MS analysis (see 7.6c and d for example 
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spectra).  Table 7.2 contains data for all samples.  The resulting spectra show that 
quadruplexes are maintained, albeit at lower abundances, for G9 annealed in Sr2+, K+, 
Ba2+, and Rb+, even after desalting, and the spectral features remain consistent with 
parallel quadruplexes.  However, the CD spectra for G9 annealed in the presence of Mg2+ 
and Na+ exhibit blue shifts for the bands from 264 nm to 257 nm and from 243 nm to 238 
nm, as well as notable decreases in overall intensities which indicates a structural change, 
most likely denaturation to the single strands.  Figure 7.6d highlights the changes seen for 
the quadruplexes annealed in the presence of Na+.  This CD data suggests that the 
quadruplexes formed around the Mg2+ and Na+ cations are less stable than those formed 
around other template cations as the salt concentration in solution decreases.   
 The final set of experiments entailed the examination of the CD spectra of the 
desalted G9 solution after the addition of ammonium acetate.  Since quadruplexes can 
form around NH4+ cations, as has been seen in both the ESI-MS data and the CD spectra, 
it was necessary to see if the addition of ammonium acetate after annealing and desalting 
would affect the survival of the original quadruplexes formed in the initial annealing step.  
For all of the solutions, the CD results indicate no dramatic change in the prevalence of 
the quadruplexes after addition of ammonium acetate (refer to CD results summarized in 
Table 7.2).  The solutions in which quadruplexes showed low prevalence after desalting 
(Li+, Mg2+, Na+, Ca2+, and Cs+) displayed only slight increases in intensities after the 
addition of ammonium acetate.  The solutions in which the initial quadruplexes were 
more prevalent (Sr2+, K+, Ba2+, and Rb+ solutions) showed modest declines in intensities. 
This series of results suggests that the surviving quadruplexes are predominantly ones 
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formed during the initial annealing procedure and that some of the less strongly bound 
template cations (Li+, Ca2+, Rb+, Cs+) can be exchanged for NH4+ without complete 
disruption or collapse of the quadruplex structures.  
 Five Ig9 solutions were chosen for further study by CD spectroscopy, and 
representative spectra are shown in Figure 7.7 for solutions annealed in Na+, K+, and 
Ba2+.   The CD spectra obtained for Ig9 annealed in the presence of Na+, NH4+, Ba2+, and 
Cs+ are similar, whereas the spectra obtained for Ig9 in the presence of K+ are quite 
different (Figure 7.7a).  Overall, the intensities of the spectral features are lower than 
observed for the G9 solutions, possibly indicating a lower degree of planarity because the 
CD signals for these complexes largely arise from base stacking.  The CD spectra of Ig9 
annealed with Na+, NH4+, Ba2+, and Cs+ exhibit strong positive bands at 307 nm and 
weaker negative bands around 289 nm. The wavelengths and intensities of spectral 
features are summarized in Table 7.3.  These features are similar to the CD spectrum 
previously reported for poly(isoguanylic acid) with a positive band at 295 nm and a 
negative band around 275 nm.  The prior measurements for poly(isoguanylic acid) were 
undertaken in 10 mM sodium chloride.52 Similar results were also obtained for individual 
isoguanine bases bound to modified sugars when analyzed in dichloromethane with 







































































Figure 7.7 CD spectra of Ig9 samples annealed in the presence of Na+, K+, and Ba2+ 
before desalting (a), after desalting (b), and after the addition of ammonium 
acetate (c).   
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Table 7.3 Wavelength maxima and corresponding intensities of major CD spectral 
features from solutions of Ig9 













Na+ 307 307 307 Na+ 1.77 1.58 1.77 
K+[a] 310 306 312 K+[a] -0.60 -0.19 -0.36 
Cs+ 308 308 308 Cs+ 0.93 0.75 1.00 
Ba2+ 306 306 306 Ba2+ 1.09 0.50 0.33 
NH4+ 307 306 306 NH4+ 0.60 0.71 0.47 
[a] K+ results are reported for the trough since the peak for this sample was 
relatively less intense. 
 
The CD spectrum obtained for Ig9 annealed in K+ was very different from the 
spectra obtained for the solutions containing other cations with a strong negative band at 
310 nm and a weak positive band at 293 nm (Figure 7.7a).  These bands contrast 
significantly from from the CD features of G9 annealed in K+, which had a positive band 
at 264 nm and a negative band at 241 nm (Figure 7.6a), thus highlighting the impact of 
the change in bases from guanine to isoguanine.  Despite the differences between the 
spectra, ESI-MS results indicate that both the G9 and Ig9 strands form quadruplexes 
under these conditions.  The notable differences in CD spectra between the quadruplexes 
presumably formed by Ig9 and G9 suggest significant conformational re-organization that 
accompanies the change from guanine to isoguanine in the strands.  The isoguanine 
quartets are not anticipated to be as planar as the guanine quartets, a factor which would 
reduce the effects of base stacking interactions and lead to distorted stacked tetrads.  
Moreover, the change from guanine to isoguanine certainly alters the optical properties of 
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the resulting quadruplexes due to the different structures of the constituent bases and their 
interactions.   
Upon desalting of the Ig9 solutions, there are slight decreases in the peak 
intensities (Figure 7.7b) that are restored after dilution of the solutions in ammonium 
acetate (Figure 7.7c).  The solution annealed in Ba2+ showed the greatest relative decrease 
in intensity after desalting and the addition of ammonium acetate, which may point to 
greater instability of the Ba2+ pentaplex in low salt environments. 
7.4.5 Ab initio calculations of isoguanine complexes.   
 To help rationalize some of the experimental findings regarding the formation of 
pentaplexes versus quadruplexes for the isoguanine strands in the presence of different 
cations, high-level ab initio optimizations were performed on three molecular symmetries 
for the smaller scale isoguanine complexes. As an example of the complexes formed, the 
optimized geometries of the Na+ complexes are shown in Figures 7.8a and 7.8b for the 
tetrads and pentads, respectively, and the corresponding B3LYP/lacv3p** energies are 
listed in Table 7.4 for the tetrads and pentads.  In each case S8 is the most stable 
conformation for the tetrads containing most of the cations except for Rb+, Cs+ and NH4+, 
which have relatively larger ionic radii than the other cations.  For the pentads, S10 is the 
most stable conformation for all five alkali metal complexes and the ones containing 
NH4+ and Ba2+.  In the optimized structures, the two (isoguanine)5 pentad units are 
approximately parallel.  Conversely, a significant degree of distortion was observed for  
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Table 7.4 The energies of the isoguanine tetrads and pentads in three symmetries at 
the B3LYP/lacv3p** level. 
















Li+  -4349.291856  8.83  0.28  Li+  -5434.732948 15.09  8.46  
Na+  -4504.083846  6.80  0.93  Na+  -5589.536896 16.07  9.51  
K+  -4369.934679  4.32  3.52  K+  -5455.400848 8.95  3.29  
Rb+  -4365.651431  2.84  -0.98  Rb+  -5451.139677 19.63  8.73  
Cs+  -4361.649461  -7.95  -0.59  Cs+  -5447.157049 16.61  9.61  
NH4+  -4398.873927  1.23  -5.65  NH4+  -5484.364241 11.58  10.23  
Mg2+  -4541.688798  17.90  1.04  Mg2+  -5627.099895 61.98  -8.23  
Ca2+  -4378.232217  11.47  0.77  Ca2+  -5463.642931 19.80  -1.15  
Sr2+  -4372.114214  8.26  0.45  Sr2+  -5457.537268 6.36  -3.36  
Ba2+  -4366.895045  0.70  0.75  Ba2+  -5452.363727 9.38  0.06  
 
the analogous tetrads, and double-bowl-like conformations were observed. The distortion 
parameter, d1, which measures the depth of the “bowl” is listed in Table 7.5 for each 
tetrad. Generally, the structures incorporating larger cations exhibited greater distortions.  
As the pentads are relatively planar, the d1 symmetry is not calculated for these 
complexes.  However, the distances between the two planar (isoguanine)5 units tended to 
increase with the radius of the cation (Table 7.5). The distortion in the tetrad planes 
compared to the planarity of the pentads supports the dominance of pentaplexes over 
quadruplexes for strands with isoguanine repeats. 
 To measure the relative template ability of each cation to promote isoguanine 
tetrads and pentads, the reaction energies, ΔE, were calculated. ΔE and the equations to 




Figure 7.8 DFT optimized geometries of the isoguanine tetrads and pentads 
coordinated with  Na+. For the tetrads, three molecular symmetries, i.e. C4h, 
D4 and S8, are shown from left to right (a). Top: the top views; bottom: the 
side views.   For the pentads, C5h, D5 and S10, are shown from left to right 




Table 7.5 The distortion parameters of isoguanine tetrads and the distances between 
isoguanine pentad units.  For the tetrads, d1 is the distance between Plane 1 
and Plane 2. d2 is the distance between the metal and the center of Plane 2.  
For the pentads, the metal is located in the geometric center of the pentad 
units. 
Tetrad  Symmetry d1 (Å) d2 (Å) Pentad Symmetry Distance (Å)  
Li+  S8  2.366 1.254 Li+  S10  3.43 
Na+  S8  2.363 1.283 Na+  S10  3.33 
K+  S8  2.845 1.612 K+  S10  3.34 
Rb+  D4  2.707 1.729 Rb+  S10  3.63 
Cs+  C4h  3.32 2.138 Cs+  S10  3.73 
NH4+  D4  3.09 1.66 NH4+  S10  4.08 
Mg2+  S8  2.572 1.18 Mg2+  D5  3.07 
Ca2+  S8  2.5 1.284 Ca2+  D5  2.91 
Sr2+  S8  2.968 1.425 Sr2+  D5  2.87 
Ba2+  S8  2.343 1.549 Ba2+  S10  2.93 
 
individually.  For the tetrads, the relative reaction energies, ΔΔE, increased moving down 
the periodic table. In contrast, this trend was not observed for the pentads as those 
incorporating K+ have larger ΔΔE values than those containing either Na+ or Rb+. It 
should be noted that the trends changed after a hydration energy correction was 
performed. For example, after the hydration energy correction, the ΔΔE values 
determined for the tetrad complexes incorporating either Na+, K+ or NH4+ were similar, 
and generally much more favorable than the values for the complexes incorporating the 
other monovalent cations.  On the other hand, ΔΔE values for pentads were more 
favorable with Rb+, Cs+ and NH4+ after the hydration energy correction. Overall, the 
energies of the pentads tended to be lower than the tetrads, supporting the tendency of the 
isoguanine strands to form pentaplexes.   
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Table 7.6 Table of energies of isoguanine tetrad and pentad formation using density 
functional theory at the B3LYP//lacv3p** level. ΔΔE is the relative reaction 
energy. For the alkali metal and ammonium complexes, the reference is the 
Li+ complex, while the reference is the Mg2+ complex for earth alkali metal 
complexes.  







Li+  S8  -4349.291856 -7.284906 -0.484702 0.00 
Na+  S8  -4504.083846 -162.08746 -0.474138 6.63 
K+  S8  -4369.934679 -27.970936 -0.441495 27.11 
Rb+  D4  -4365.652992 -23.705936 -0.424808 37.58 
Cs+  C4h  -4361.66213 -19.732039 -0.407843 48.23 
NH4+  D4  -4398.882934 -56.920092 -0.440594 27.68 
Mg2+  S8  -4541.688798 -199.240881 -0.925669 0.00 
Ca2+  S8  -4378.232217 -35.883928 -0.826041 62.52 
Sr2+  S8  -4372.114214 -29.812995 -0.778971 92.05 
Ba2+  S8  -4366.895045 -24.654361 -0.718436 130.04 







Li+  S10  -5434.732948 -7.284906 -0.545232 0.00 
Na+  S10  -5589.536896 -162.08746 -0.546626 -0.88 
K+  S10  -5455.400848 -27.970936 -0.527102 11.38 
Rb+  S10  -5451.139677 -23.705936 -0.530931 8.97 
Cs+  S10  -5447.157049 -19.732039 -0.5222 14.45 
NH4+  S10  -5484.364241 -56.920092 -0.541339 2.44 
Mg2+  D5  -5627.113004 -199.240881 -0.969313 0.00 
Ca2+  D5  -5463.644766 -35.883928 -0.858028 69.83 
Sr2+  D5  -5457.542618 -29.812995 -0.826813 89.42 
Ba2+  S10  -5452.363727 -24.654361 -0.806556 102.13 
[a] For the tetrads, ΔE, the reaction energy, is calculated using the following equation: ΔE 
= Ecomplex – (Eion + 8× Eisoguanine), where the energy of isoguanine is - 542.690281 
hartrees.  
[b] For the pentads, ΔE, the reaction energy, is calculated using the following equation: 





 The distortion energy, which is the difference between the energies of the fully 
optimized structures and the partially optimized geometries with the enforcement of the 
planarity of the isoguanine units, is listed in Table 7.7 for each tetrad.  Interestingly, 
tetrads containing NH4+ or K+ had the smallest distortion energies of all the complexes. 
This implies that a smaller energetic penalty was paid by incorporation of NH4+ or K+ 
upon formation of planar isoguanine tetrads compared to incorporation of other cations. 
This finding is consistent with the ESI-MS results showing that quadruplexes were the 
dominant species formed for strands annealed in high concentrations of K+ and NH4+.   
Table 7.7 The distortion energies of the most stable symmetry of isoguanine tetrads. 
The distortion energy, Edistortion = Econstrain – E, where Econstrain is the energy of 
the partially optimized geometry forcing the two tetrad planes parallel to 
each other, and E is the energy of the fully optimized geometry. The 
distance between two isoguanine planes are also listed. 






Li+  S8  20.65 3.24 
Na+  S8  16.48 3.33 
K+  S8  13.73 3.52 
Rb+  D4  17.43 3.79 
Cs+  C4h  25.47 4.34 
NH4+  D4  11.66 3.78 
Mg2+  S8  46.87 3.07 
Ca2+  S8  38.52 3.21 
Sr2+  S8  34.31 3.28 
Ba2+  S8  29.55 3.42 
 
The greater ΔΔE of the K+-containing pentads in comparison to those incorporating 
neighboring cations Na+ and Rb+ may be another driving force for the formation of  
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quadruplexes over pentaplexes in the presence of K+.  The low distortion energies of the 
tetrads containing K+ or NH4+ support the formation of isoguanine quadruplexes around 
these cations despite the lower energies of tetrads formed around smaller cations.  The 
increased template abilities of K+ and NH4+ with respect to formation of planar tetrad 
units appears to facilitate quadruplex formation over pentaplex formation under certain 
conditions despite the higher energy of the tetrads.   
7.5 CONCLUSIONS   
 Quadruplexes and pentaplexes of G9 and Ig9, respectively, were annealed in 
solutions containing cations of varying charge and ionic radius.  The formation of G9 
quadruplexes was far more dependent on the identity of the central cation than the 
formation of Ig9 complexes.  While Ig9 complexes were formed around all of the cations, 
annealing in only six of the ten cations produced high levels of G9 quadruplexes.  In 
addition, five of various annealing cations, including Li+, Mg2+, Na+, Ca2+, and Rb+, were 
not retained but instead were replaced by NH4+ in the Ig9 pentaplexes when ammonium 
acetate was added to the solutions immediately before ESI-MS analysis.  This was only 
true for G9 quadruplexes annealed in the presence of Li+, Ca2+, Rb+, and Cs+.  The ready 
exchange of central cations points to the utility of the Ig9 pentaplexes as efficient 
monovalent cation channels.  Also, ab initio calculations indicate that the formation of 
planar isoguanine tetrads around the template cations K+ and NH4+ require the least 
amount of energy, thus offering some rationalization for the formation of quadruplexes in 
the presence of high concentrations of these cations.  CD results also confirm that many 
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of the complexes retain their higher order structure throughout the desalting process, thus 
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Chapter 8: Conclusions 
 
 The work presented in this dissertation provides greater insight into the 
interactions of ligands with DNA and intermolecular interactions of DNA and the extent 
to which mass spectrometry can be used to further improve our understanding of those 
interactions.  Binding affinities and selectivities were determined for non-covalent 
binding ligands while the binding affinities and binding sites were determined for 
covalently bound ligands.  Covalent and non-covalent interactions are crucial for the both 
cellular function and for ligand binding, and insight into both types of interactions is 
valuable for the design of more selective DNA interactive agents or modulation of 
binding affinities. 
 The studies involving the non-covalent interactions of ligands to quadruplexes 
were described in chapters 3 and 4.  The study of pyrrole inosine ligands, discussed in 
chapter 3, reported the use of ESI-MS to characterize non-covalent DNA interactions.  
Comparison of the binding of the three ligands indicated that the ligand designed to form 
a three-point Hoosteen interaction with guanine bound specifically to quadruplexes and 
guanine-rich duplexes.  The ligand that could only form a two point interaction bound 
oligonucleotides with a variety of secondary structures regardless of the presence of 
guanines.  When the third binding functionality was replaced by a bulky blocking group, 
binding to all sequences was greatly diminished.  These results were obtained quickly and 
highlight the ability of ESI-MS to be used for determining the relative specificity of a 
 163 
series of ligands.  In addition, dissociation spectra were used to determine the type of 
non-covalent interaction observed with the ligands.  The dissociation pattern indicated 
that the pyrrole inosine ligand stacked on the end of the quadruplexes and intercalated 
into the duplexes.  These results were obtained during the same experiments used to 
determine the binding specificity providing valuable information without using additional 
time or sample.  The Pt ligands that bound to quadruplex DNA were described in chapter 
4.  In this work, the size and shape of the Pt-centered complexes improved the interaction 
with quadruplexes in comparison to other ligands.  A small Pt-based complex and a 
larger, non-planar Ru-based complex did not exhibit the same enhanced binding affinity 
to quadruplex oligonucleotides.  In addition, it was determined that the specific structural 
motifs at the ends of the quadruplex, where the ligands bound, had an effect on whether 
the ligands would complex with the DNA.  Binding to anti-parallel intramolecular 
quadruplexes or to tetramolecular quadruplexes was observed, but not binding to parallel 
intramolecular quadruplexes.  These results, obtained through a combination of CD and 
MS analysis, highlights the advantages of mass spectrometry and how additional 
information gained through other complementary experiments can be used to more fully 
characterize DNA/ligand complexes.   
 In chapter 5 the interactions of anthracycline ligands, doxorubicin and 
daunorubicin, with both wild-type and mismatched hairpin DNA were evaluated.  The 
ligands both exhibited enhanced binding to the mismatched sequences.  Non-specific 
binding was observed when the concentration of ligand exceeded that of the DNA, 
resulting in complexes with high ligand:DNA stoichiometries.  Mass spectrometry 
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allowed determination of the stoichiometries of the DNA/ligand complexes as well as 
afforded rapid screening of solutions with varying DNA/ligand concentration ratios.   
 The interstrand crosslinking of duplex DNA was discussed in chapter 6.  
Diaziridinyl benzoquinone crosslinkers were reduced in vitro and reacted with duplex 
DNA.  Analysis by LC-MS indicated that crosslinks were formed with both crosslinkers 
when a 5’-GNC or 5’-GNNC sequence was present in the duplex.  However, reactions 
with duplexes with 5’-GC or 5’-CG sequences did not result in crosslinks.  In order for 
the crosslinks to form, it was necessary to have a minimum distance between opposite 
strand guanine bases.  In addition, terminal target sequences did not result in the 
formation of crosslinks indicating that a specific secondary structure was necessary for 
crosslink formation.  The diaziridinyl benzoquinone with a phenyl substituent did not 
form crosslinks as well as the methyl substituted benzoquinone indicating the bulky 
phenyl group  limited the binding affinity or reactivity.  ESI-MS was used not only to 
verify the formation of crosslinked products, but were also used to determine the site of 
crosslinking based on tandem mass spectrometry.   
 The final chapter explored non-covalent interactions between DNA strands.  
Strands containing either isoguanine or guanine were annealed with different monovalent 
or divalent cations to determine how those scaffold cations would affect the secondary 
structure of the DNA.  While guanine-containing strands only formed quadruplexes and 
only formed them around a few selected cations, sequences incorporating isoguanine 
formed pentaplexes around most of the cations studied.  Quadruplexes were observed 
even when the annealing cation was potassium or ammonium, but the structures formed 
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around the other cations, no matter the charge or cationic radius, were pentaplexes.  Not 
only was the presence of four or five strands easily determined based on the m/z ratio of 
the complexes, both the identity and the number of cations present in the central cavity of 
the complex were also readily determined.   
 The work described in this dissertation demonstrates the range of information that 
can be gained from the mass spectrometric investigation of DNA complexes.  In addition 
to determining the affinities and selectivities of ligands, binding sites can also be 
interrogated and determined by tandem mass spectrometry.  These techniques can be 
used to study non-covalent and covalent DNA binding ligands especially for the 
identification and characterization of anti-cancer and anti-biotic agents which frequently 
bind to DNA.  Given the speed and low sample sizes required for MS analysis, these 
techniques could be readily applied to high-throughput drug screening.   
 Future work in this area would certainly focus on  using LC-MS to investigate 
covalent interactions and crosslinks.  While the research presented in chapter 6 is the 
place to begin, work to improve detection limits would permit the investigation of even 
smaller samples and detection of crosslinks in vivo.  This might be accomplished through 
even more sensitive separation/mass analyzer combinations or through improvements in 
the reaction efficiencies.  In addition, using tandem mass spectrometry to determine 
relative crosslinking efficiencies of various binding/crosslinking sites would more easily 
permit the identification of ideal covalent binding sites.  As this work is extended to 
larger ligands and, in the future, to peptides and proteins, determining a way to analyze 
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large DNA/protein complexes will be necessary as these large complexes are not easily 
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